| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 BACE1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 REN ERVK-8 | 2.47e-12 | 37 | 202 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 ABCB7 ATP7A SPAST ATP7B CCT3 ATP8A2 ATP10B ATP9B CHD4 KATNAL1 MOV10L1 ATP2C2 ATP11A ABCC10 ATP8B3 SMARCA5 VPS4B KATNA1 ATP10A ATP10D ATP2C1 CHD5 ATP2A2 KIF1C | 3.30e-12 | 441 | 202 | 25 | GO:0016887 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 BACE1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 REN ERVK-8 | 3.32e-12 | 38 | 202 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 ABCB7 ATP7A SPAST ATP7B CCT3 ATP8A2 ATP10B ATP9B CHD4 KATNAL1 CCT8L2 UBA7 MOV10L1 ATP2C2 ATP11A ABCC10 ATP8B3 SMARCA5 VPS4B MSH3 KATNA1 ATP10A ATP10D ATP2C1 CHD5 CCT8L1P ATP2A2 KIF1C | 4.92e-12 | 614 | 202 | 29 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.49e-10 | 28 | 202 | 8 | GO:0140326 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.96e-09 | 51 | 202 | 9 | GO:0140303 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA2 ABCB7 ATP7A SPAST ATP7B CCT3 ATP8A2 ATP10B ATP9B CHD4 KATNAL1 MOV10L1 ATP2C2 ATP11A ABCC10 ATP8B3 SMARCA5 VPS4B KATNA1 ATP10A ATP10D RHOH ATP2C1 GPN2 CHD5 ATP2A2 KIF1C | 2.14e-08 | 775 | 202 | 27 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA2 ABCB7 ATP7A SPAST ATP7B CCT3 ATP8A2 LHPP ATP10B ATP9B CHD4 KATNAL1 MOV10L1 ATP2C2 ATP11A ABCC10 ATP8B3 SMARCA5 VPS4B KATNA1 ATP10A ATP10D RHOH ATP2C1 GPN2 CHD5 ATP2A2 KIF1C | 2.85e-08 | 839 | 202 | 28 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA2 ABCB7 ATP7A SPAST ATP7B CCT3 ATP8A2 LHPP ATP10B ATP9B CHD4 KATNAL1 MOV10L1 ATP2C2 ATP11A ABCC10 ATP8B3 SMARCA5 VPS4B KATNA1 ATP10A ATP10D RHOH ATP2C1 GPN2 CHD5 ATP2A2 KIF1C | 2.92e-08 | 840 | 202 | 28 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA2 ABCB7 ATP7A SPAST ATP7B CCT3 ATP8A2 LHPP ATP10B ATP9B CHD4 KATNAL1 MOV10L1 ATP2C2 ATP11A ABCC10 ATP8B3 SMARCA5 VPS4B KATNA1 ATP10A ATP10D RHOH ATP2C1 GPN2 CHD5 ATP2A2 KIF1C | 2.92e-08 | 840 | 202 | 28 | GO:0016818 |
| GeneOntologyMolecularFunction | transporter activity | ANO9 ABCA2 ABCB7 ATP7A ATP7B ATP8A2 ATP10B ATP9B SPNS3 MFSD4B CCT8L2 KCNC1 ATP2C2 ATP11A SLC49A3 SEC61A1 CNGB1 ABCC10 ATP8B3 SLC11A2 ATG2B MFSD4A SLC1A1 ATP10A SLC1A6 ATP10D RHD SLC3A1 ATP2C1 P2RX7 MTTP SLC35F2 SLC24A1 ATP2A2 SLC37A4 | 7.94e-08 | 1289 | 202 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | floppase activity | 4.02e-07 | 16 | 202 | 5 | GO:0140328 | |
| GeneOntologyMolecularFunction | flippase activity | 5.65e-07 | 17 | 202 | 5 | GO:0140327 | |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 1.02e-06 | 3 | 202 | 3 | GO:0140351 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.38e-06 | 20 | 202 | 5 | GO:0046624 | |
| GeneOntologyMolecularFunction | magnesium ion binding | IMPA1 ATP8A2 ATP10B ATP9B MOV10L1 ATP11A ALPP ATP8B3 NT5C3B ATP10A ATP10D P2RX7 HACL1 | 1.48e-06 | 247 | 202 | 13 | GO:0000287 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.80e-06 | 21 | 202 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.17e-06 | 11 | 202 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | deaminase binding | 4.05e-06 | 4 | 202 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ANO9 ABCA2 ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATG2B ATP10A ATP10D MTTP | 5.24e-06 | 196 | 202 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 PSMB6 BACE1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 FAP PRSS53 LMLN CPNE1 ERVK-19 ERVK-24 REN FURIN ERVK-8 | 8.35e-06 | 430 | 202 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.40e-06 | 14 | 202 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 9.40e-06 | 14 | 202 | 4 | GO:0140333 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 9.91e-06 | 74 | 202 | 7 | GO:0005548 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.51e-05 | 109 | 202 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.95e-05 | 36 | 202 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.95e-05 | 36 | 202 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | copper ion transmembrane transporter activity | 5.50e-05 | 8 | 202 | 3 | GO:0005375 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 7.95e-05 | 44 | 202 | 5 | GO:0046915 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 8.19e-05 | 9 | 202 | 3 | GO:0090556 | |
| GeneOntologyMolecularFunction | microtubule severing ATPase activity | 8.19e-05 | 9 | 202 | 3 | GO:0008568 | |
| GeneOntologyMolecularFunction | P-type divalent copper transporter activity | 1.02e-04 | 2 | 202 | 2 | GO:0043682 | |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 1.02e-04 | 2 | 202 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | P-type monovalent copper transporter activity | 1.02e-04 | 2 | 202 | 2 | GO:0140581 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 1.16e-04 | 10 | 202 | 3 | GO:0005384 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 ABCA2 ABCB7 ATP7A ATP7B SPNS3 MFSD4B CCT8L2 KCNC1 ATP2C2 SLC49A3 SEC61A1 CNGB1 ABCC10 SLC11A2 MFSD4A SLC1A1 SLC1A6 RHD SLC3A1 ATP2C1 P2RX7 SLC35F2 SLC24A1 ATP2A2 SLC37A4 | 1.55e-04 | 1180 | 202 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.59e-04 | 11 | 202 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 PSMB6 BACE1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 GGT5 FAP PRSS53 LMLN CPNE1 ERVK-19 ERVK-24 REN FURIN ERVK-8 | 3.69e-04 | 654 | 202 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA2 ABCB7 ATP7A ATP7B MFSD4B ATP2C2 ABCC10 SLC11A2 SLC1A1 SLC1A6 ATP2C1 SLC24A1 ATP2A2 SLC37A4 | 3.73e-04 | 477 | 202 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 4.09e-04 | 62 | 202 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 4.24e-04 | 15 | 202 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 4.24e-04 | 15 | 202 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 4.70e-04 | 178 | 202 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.17e-04 | 37 | 202 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.73e-04 | 38 | 202 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7A ATP7B CCT8L2 KCNC1 ATP2C2 SEC61A1 CNGB1 SLC11A2 SLC1A1 SLC1A6 ATP2C1 SLC24A1 ATP2A2 | 9.42e-04 | 465 | 202 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 9.98e-04 | 5 | 202 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 9.98e-04 | 5 | 202 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 9.98e-04 | 5 | 202 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.02e-03 | 20 | 202 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.02e-03 | 20 | 202 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.19e-03 | 46 | 202 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 1.49e-03 | 6 | 202 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.76e-03 | 24 | 202 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 ATP7A ATP7B CCT8L2 KCNC1 ATP2C2 SEC61A1 CNGB1 ABCC10 SLC11A2 SLC1A1 SLC1A6 RHD ATP2C1 SLC24A1 ATP2A2 SLC37A4 | 1.86e-03 | 758 | 202 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | telomerase RNA binding | 1.99e-03 | 25 | 202 | 3 | GO:0070034 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 2.07e-03 | 7 | 202 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 2.07e-03 | 7 | 202 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | phosphatase activity | 2.67e-03 | 287 | 202 | 9 | GO:0016791 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7A ATP7B ATP2C2 SLC11A2 SLC1A1 SLC1A6 ATP2C1 SLC24A1 ATP2A2 | 3.66e-03 | 301 | 202 | 9 | GO:0022853 |
| GeneOntologyBiologicalProcess | lipid translocation | ANO9 ABCA2 ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATP10A ATP10D P2RX7 | 2.90e-10 | 60 | 200 | 10 | GO:0034204 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | ANO9 ABCA2 ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATP10A ATP10D P2RX7 | 6.60e-10 | 65 | 200 | 10 | GO:0097035 |
| GeneOntologyBiologicalProcess | phospholipid translocation | 2.74e-09 | 55 | 200 | 9 | GO:0045332 | |
| GeneOntologyBiologicalProcess | phospholipid transport | ANO9 ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATP10A ATP10D P2RX7 MTTP | 8.33e-08 | 106 | 200 | 10 | GO:0015914 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | ERVK-6 HNRNPCL1 CCT3 ERVK-7 ERVK-10 HNRNPC HNRNPCL3 PARP4 ERVK-8 | 1.12e-07 | 83 | 200 | 9 | GO:0006278 |
| GeneOntologyBiologicalProcess | lipid transport | ANO9 ABCA2 ATP8A2 ATP10B ATP9B SPNS3 OSBPL11 ATP11A ABCC10 ATP8B3 VPS4B ATG2B REN ATP10A ATP10D VPS13D P2RX7 FURIN MTTP | 5.36e-07 | 506 | 200 | 19 | GO:0006869 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | ANO9 ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATP10A ATP10D P2RX7 MTTP SLC37A4 | 5.40e-07 | 162 | 200 | 11 | GO:0015748 |
| GeneOntologyBiologicalProcess | lipid localization | ANO9 ABCA2 ATP8A2 ATP10B ATP9B SPNS3 OSBPL11 ATP11A ABCC10 ATP8B3 VPS4B ATG2B REN ATP10A ATP10D VPS13D P2RX7 FURIN MTTP | 2.74e-06 | 565 | 200 | 19 | GO:0010876 |
| GeneOntologyBiologicalProcess | DNA integration | 5.73e-06 | 13 | 200 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 1.76e-05 | 6 | 200 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | membrane organization | ANO9 ABCA2 SPAST ATP8A2 ATP10B ATP9B MOAP1 ATP11A SEC61A1 MUL1 ATP8B3 VPS4B ATG2B HUWE1 RUFY1 ATP10A ATP10D ATP2C1 P2RX7 TRAPPC12 FER1L4 MTTP ATP2A2 | 2.85e-05 | 914 | 200 | 23 | GO:0061024 |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 3.05e-05 | 7 | 200 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | ERVK-6 HNRNPCL1 CCT3 ERVK-7 ERVK-10 RRM1 HNRNPC HNRNPCL3 PARP4 ERVK-8 | 5.55e-05 | 218 | 200 | 10 | GO:0071897 |
| GeneOntologyBiologicalProcess | microtubule severing | 7.23e-05 | 9 | 200 | 3 | GO:0051013 | |
| GeneOntologyBiologicalProcess | copper ion transmembrane transport | 7.23e-05 | 9 | 200 | 3 | GO:0035434 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 9.95e-05 | 48 | 200 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 1.18e-04 | 113 | 200 | 7 | GO:0000041 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 1.85e-04 | 12 | 200 | 3 | GO:0071421 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.20e-04 | 31 | 200 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | copper ion export | 2.79e-04 | 3 | 200 | 2 | GO:0060003 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.07e-09 | 14 | 201 | 6 | GO:1990531 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 1.71e-05 | 6 | 201 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | trans-Golgi network | ATP7A ATP7B BACE1 ATP9B KLHL20 ATP2C2 ARAP1 ATP8B3 SLC11A2 POSTN ATP2C1 FURIN | 4.33e-05 | 306 | 201 | 12 | GO:0005802 |
| GeneOntologyCellularComponent | proteasome storage granule | 9.20e-05 | 2 | 201 | 2 | GO:0034515 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 1.37e-04 | 11 | 201 | 3 | GO:0005832 | |
| GeneOntologyCellularComponent | vesicle membrane | MON2 ABCA2 ATP7A ATP8A2 INPP5B BACE1 DGKQ ATP10B ITGA2B FZD7 CPNE3 OSBPL11 CPNE1 ATP11A TAB1 SEC61A1 CNGB1 ATP8B3 SLC11A2 DSP WNT7A VPS4B CANX RUFY1 SLC1A1 ARFGEF3 FURIN | 1.80e-04 | 1325 | 201 | 27 | GO:0012506 |
| GeneOntologyCellularComponent | proteasome regulatory particle, base subcomplex | 1.81e-04 | 12 | 201 | 3 | GO:0008540 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 ABCA2 ATP7A ATP8A2 INPP5B BACE1 ATP10B ITGA2B FZD7 CPNE3 OSBPL11 CPNE1 ATP11A TAB1 SEC61A1 CNGB1 ATP8B3 SLC11A2 DSP WNT7A VPS4B CANX RUFY1 SLC1A1 ARFGEF3 FURIN | 3.46e-04 | 1307 | 201 | 26 | GO:0030659 |
| GeneOntologyCellularComponent | proteasome complex | 4.66e-04 | 67 | 201 | 5 | GO:0000502 | |
| GeneOntologyCellularComponent | cell-cell junction | ATP7B LAMA1 MPDZ PDLIM3 YAP1 TLN2 PDLIM2 DSP SPECC1L PLEKHG4B TGM1 P2RX7 TLN1 ATP2A2 CDH13 | 6.23e-04 | 591 | 201 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | protein folding chaperone complex | 6.98e-04 | 42 | 201 | 4 | GO:0101031 | |
| GeneOntologyCellularComponent | endosome membrane | MON2 ABCA2 ATP7A ATP8A2 INPP5B BACE1 ATP10B FZD7 OSBPL11 TAB1 SLC11A2 VPS4B RUFY1 SLC1A1 FURIN | 7.51e-04 | 602 | 201 | 15 | GO:0010008 |
| GeneOntologyCellularComponent | katanin complex | 9.03e-04 | 5 | 201 | 2 | GO:0008352 | |
| GeneOntologyCellularComponent | proteasome regulatory particle | 1.18e-03 | 22 | 201 | 3 | GO:0005838 | |
| GeneOntologyCellularComponent | anchoring junction | IL16 ATP7B LAMA1 MPDZ ITGA2B FAP PDLIM3 YAP1 LMLN CPNE3 TLN2 PDLIM2 DSP SPECC1L PLEKHG4B TGM1 P2RX7 TLN1 ATP2A2 CDH13 | 1.21e-03 | 976 | 201 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | brush border membrane | 1.24e-03 | 83 | 201 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | ATP7A ATP7B BACE1 ATP9B KLHL20 ATP2C2 ARAP1 ATP8B3 SLC11A2 POSTN ATP2C1 FURIN | 1.25e-03 | 443 | 201 | 12 | GO:0098791 |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 1.72e-03 | 25 | 201 | 3 | GO:0005697 | |
| GeneOntologyCellularComponent | proteasome accessory complex | 1.72e-03 | 25 | 201 | 3 | GO:0022624 | |
| GeneOntologyCellularComponent | peptidase complex | 1.83e-03 | 133 | 201 | 6 | GO:1905368 | |
| GeneOntologyCellularComponent | cerebellar granule cell to Purkinje cell synapse | 1.87e-03 | 7 | 201 | 2 | GO:0150048 | |
| GeneOntologyCellularComponent | endosome | MON2 TNIK ABCA2 ATP7A SPAST ATP7B ATP8A2 INPP5B BACE1 DGKQ ATP10B ATP9B FZD7 OSBPL11 ATP11A TAB1 SLC11A2 VPS4B RUFY1 SLC1A1 ARSA FURIN | 1.99e-03 | 1167 | 201 | 22 | GO:0005768 |
| GeneOntologyCellularComponent | pronucleus | 2.40e-03 | 28 | 201 | 3 | GO:0045120 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | HNRNPCL1 LAMA1 NARS1 EVX1 CHD4 RRM1 HNRNPC HNRNPCL3 NUP205 TXNRD1 FASN DLD METTL16 HEATR5B NRBP1 SMARCA5 DSP ZNF407 VPS13D TLN1 RBPJ TTI1 ATP2A2 KDM1A | 3.90e-06 | 779 | 153 | 24 | MP:0014257 |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | HNRNPCL1 LAMA1 NARS1 EVX1 CHD4 RRM1 HNRNPC HNRNPCL3 NUP205 TXNRD1 FASN DLD METTL16 NRBP1 SMARCA5 DSP ZNF407 VPS13D TLN1 RBPJ TTI1 ATP2A2 KDM1A | 1.10e-05 | 772 | 153 | 23 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage | MON2 RNF121 HNRNPCL1 CCT3 LAMA1 NARS1 PSMD2 EVX1 CHD4 RRM1 HNRNPC HNRNPCL3 NUP205 TXNRD1 TTBK2 FASN PTPN14 DLD METTL16 HEATR5B ALPP NRBP1 SMARCA5 CAD DSP ZNF407 VPS13D FURIN TLN1 RBPJ TTI1 ATP2A2 KDM1A | 1.28e-05 | 1383 | 153 | 33 | MP:0013293 |
| MousePheno | embryonic lethality prior to organogenesis | MON2 HNRNPCL1 CCT3 LAMA1 NARS1 PSMD2 EVX1 CHD4 RRM1 HNRNPC HNRNPCL3 NUP205 TXNRD1 FASN PTPN14 DLD METTL16 ALPP NRBP1 SMARCA5 CAD DSP ZNF407 VPS13D TLN1 RBPJ TTI1 ATP2A2 KDM1A | 4.04e-05 | 1204 | 153 | 29 | MP:0013292 |
| MousePheno | abnormal kidney copper level | 1.19e-04 | 2 | 153 | 2 | MP:0010242 | |
| MousePheno | increased kidney copper level | 1.19e-04 | 2 | 153 | 2 | MP:0010243 | |
| MousePheno | increased brain copper level | 1.19e-04 | 2 | 153 | 2 | MP:0011214 | |
| MousePheno | embryonic lethality between implantation and placentation, complete penetrance | HNRNPCL1 LAMA1 HNRNPC HNRNPCL3 TXNRD1 DLD METTL16 NRBP1 SMARCA5 DSP VPS13D TLN1 RBPJ TTI1 ATP2A2 KDM1A | 1.36e-04 | 506 | 153 | 16 | MP:0011095 |
| MousePheno | embryonic lethality between implantation and placentation | HNRNPCL1 CCT3 LAMA1 HNRNPC HNRNPCL3 TXNRD1 DLD METTL16 NRBP1 SMARCA5 DSP VPS13D TLN1 RBPJ TTI1 ATP2A2 KDM1A | 1.51e-04 | 565 | 153 | 17 | MP:0009850 |
| Domain | ATPase_P-typ_P_site | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 9.33e-16 | 36 | 191 | 12 | IPR018303 |
| Domain | P_typ_ATPase | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 9.33e-16 | 36 | 191 | 12 | IPR001757 |
| Domain | ATPASE_E1_E2 | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 9.33e-16 | 36 | 191 | 12 | PS00154 |
| Domain | ATPase_P-typ_transduc_dom_A | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 1.37e-15 | 37 | 191 | 12 | IPR008250 |
| Domain | E1-E2_ATPase | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 1.37e-15 | 37 | 191 | 12 | PF00122 |
| Domain | HAD-like_dom | ATP7A ATP7B NANP ATP8A2 LHPP ATP10B ATP9B ATP2C2 ATP11A ATP8B3 NT5C3B ATP10A ATP10D ATP2C1 ATP2A2 | 2.44e-15 | 79 | 191 | 15 | IPR023214 |
| Domain | ATPase_P-typ_cyto_domN | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2A2 | 3.23e-14 | 35 | 191 | 11 | IPR023299 |
| Domain | - | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATP10A ATP10D ATP2A2 | 5.24e-13 | 32 | 191 | 10 | 3.40.1110.10 |
| Domain | - | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP11A ATP8B3 ATP10A ATP10D ATP2A2 | 5.24e-13 | 32 | 191 | 10 | 2.70.150.10 |
| Domain | - | ATP7A ATP7B NANP ATP8A2 LHPP ATP10B ATP9B ATP11A ATP8B3 NT5C3B ATP10A ATP10D | 1.91e-12 | 64 | 191 | 12 | 3.40.50.1000 |
| Domain | P_typ_ATPase_c | 3.38e-11 | 14 | 191 | 7 | IPR032630 | |
| Domain | P-type_ATPase_N | 3.38e-11 | 14 | 191 | 7 | IPR032631 | |
| Domain | P-type_ATPase_IV | 3.38e-11 | 14 | 191 | 7 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 3.38e-11 | 14 | 191 | 7 | PF16212 | |
| Domain | PhoLip_ATPase_N | 3.38e-11 | 14 | 191 | 7 | PF16209 | |
| Domain | Hydrolase_3 | 2.57e-08 | 10 | 191 | 5 | PF08282 | |
| Domain | Vps4_C | 7.19e-07 | 8 | 191 | 4 | IPR015415 | |
| Domain | Vps4_C | 7.19e-07 | 8 | 191 | 4 | PF09336 | |
| Domain | hnRNP_C | 2.06e-05 | 6 | 191 | 3 | IPR017347 | |
| Domain | - | 1.04e-04 | 2 | 191 | 2 | 1.20.1420.10 | |
| Domain | VBS | 1.04e-04 | 2 | 191 | 2 | PF08913 | |
| Domain | KATNA1 | 1.04e-04 | 2 | 191 | 2 | IPR028596 | |
| Domain | P-typ_ATPase_IB | 1.04e-04 | 2 | 191 | 2 | IPR027256 | |
| Domain | Vinculin-bd_dom | 1.04e-04 | 2 | 191 | 2 | IPR015009 | |
| Domain | Talin_cent | 1.04e-04 | 2 | 191 | 2 | IPR015224 | |
| Domain | Talin_middle | 1.04e-04 | 2 | 191 | 2 | PF09141 | |
| Domain | HMA_Cu_ion-bd | 1.04e-04 | 2 | 191 | 2 | IPR006122 | |
| Domain | P-type_ATPase_IIA_PMR1 | 1.04e-04 | 2 | 191 | 2 | IPR006413 | |
| Domain | ATPase_AAA_CS | 2.06e-04 | 29 | 191 | 4 | IPR003960 | |
| Domain | ASP_PROTEASE | 2.16e-04 | 12 | 191 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 2.79e-04 | 13 | 191 | 3 | IPR001969 | |
| Domain | CHD_N | 3.10e-04 | 3 | 191 | 2 | IPR012958 | |
| Domain | CHD_C2 | 3.10e-04 | 3 | 191 | 2 | IPR012957 | |
| Domain | PC_rep | 3.10e-04 | 3 | 191 | 2 | PF01851 | |
| Domain | Talin-1 | 3.10e-04 | 3 | 191 | 2 | IPR015710 | |
| Domain | CHDCT2 | 3.10e-04 | 3 | 191 | 2 | PF08074 | |
| Domain | CHDNT | 3.10e-04 | 3 | 191 | 2 | PF08073 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | IPR009462 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | IPR009463 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | PF06465 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | PF06461 | |
| Domain | Proteasome/cyclosome_rpt | 3.10e-04 | 3 | 191 | 2 | IPR002015 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | SM01147 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | SM01146 | |
| Domain | Heavy-metal-associated_CS | 3.10e-04 | 3 | 191 | 2 | IPR017969 | |
| Domain | AAA | 3.87e-04 | 34 | 191 | 4 | PS00674 | |
| Domain | ATPase_P-typ_TM_dom | 5.34e-04 | 16 | 191 | 3 | IPR023298 | |
| Domain | - | 5.34e-04 | 16 | 191 | 3 | 1.20.1110.10 | |
| Domain | ILWEQ_dom | 6.16e-04 | 4 | 191 | 2 | IPR002558 | |
| Domain | ILWEQ | 6.16e-04 | 4 | 191 | 2 | SM00307 | |
| Domain | HMA | 6.16e-04 | 4 | 191 | 2 | PF00403 | |
| Domain | DCB_dom | 6.16e-04 | 4 | 191 | 2 | IPR032629 | |
| Domain | FERM_f0 | 6.16e-04 | 4 | 191 | 2 | PF16511 | |
| Domain | ILWEQ | 6.16e-04 | 4 | 191 | 2 | PD011820 | |
| Domain | - | 6.16e-04 | 4 | 191 | 2 | 1.20.1410.10 | |
| Domain | Sec7_C | 6.16e-04 | 4 | 191 | 2 | IPR015403 | |
| Domain | DUF1981 | 6.16e-04 | 4 | 191 | 2 | PF09324 | |
| Domain | I_LWEQ | 6.16e-04 | 4 | 191 | 2 | PF01608 | |
| Domain | I_LWEQ | 6.16e-04 | 4 | 191 | 2 | PS50945 | |
| Domain | FERM_f0 | 6.16e-04 | 4 | 191 | 2 | IPR032425 | |
| Domain | HMA_2 | 6.16e-04 | 4 | 191 | 2 | PS50846 | |
| Domain | DCB | 6.16e-04 | 4 | 191 | 2 | PF16213 | |
| Domain | HMA_1 | 6.16e-04 | 4 | 191 | 2 | PS01047 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.44e-04 | 17 | 191 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 6.44e-04 | 17 | 191 | 3 | PF00689 | |
| Domain | AAA | 7.09e-04 | 144 | 191 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 7.09e-04 | 144 | 191 | 7 | IPR003593 | |
| Domain | Cation_ATPase_N | 7.67e-04 | 18 | 191 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 7.67e-04 | 18 | 191 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 9.04e-04 | 19 | 191 | 3 | IPR004014 | |
| Domain | Pyr_OxRdtase_I_AS | 1.02e-03 | 5 | 191 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 1.02e-03 | 5 | 191 | 2 | PF02852 | |
| Domain | PYRIDINE_REDOX_1 | 1.02e-03 | 5 | 191 | 2 | PS00076 | |
| Domain | MFS_1 | 1.16e-03 | 77 | 191 | 5 | PF07690 | |
| Domain | MFS | 1.16e-03 | 77 | 191 | 5 | IPR011701 | |
| Domain | DUF4749 | 1.52e-03 | 6 | 191 | 2 | PF15936 | |
| Domain | DUF4749 | 1.52e-03 | 6 | 191 | 2 | IPR031847 | |
| Domain | FERM_CS | 1.82e-03 | 24 | 191 | 3 | IPR019747 | |
| Domain | AAA | 1.96e-03 | 52 | 191 | 4 | PF00004 | |
| Domain | NAD(P)-bd_dom | 2.05e-03 | 173 | 191 | 7 | IPR016040 | |
| Domain | - | 2.11e-03 | 7 | 191 | 2 | 3.30.390.30 | |
| Domain | Vinculin/catenin | 2.11e-03 | 7 | 191 | 2 | IPR006077 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 2.11e-03 | 7 | 191 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 2.11e-03 | 7 | 191 | 2 | PS00714 | |
| Domain | SDF | 2.11e-03 | 7 | 191 | 2 | PF00375 | |
| Domain | - | 2.11e-03 | 7 | 191 | 2 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 2.11e-03 | 7 | 191 | 2 | IPR001991 | |
| Domain | HMA_dom | 2.11e-03 | 7 | 191 | 2 | IPR006121 | |
| Domain | Na-dicarboxylate_symporter_CS | 2.11e-03 | 7 | 191 | 2 | IPR018107 | |
| Domain | ATPase_AAA_core | 2.25e-03 | 54 | 191 | 4 | IPR003959 | |
| Domain | - | 2.57e-03 | 56 | 191 | 4 | 3.50.50.60 | |
| Domain | ARM-type_fold | 2.64e-03 | 339 | 191 | 10 | IPR016024 | |
| Domain | FAD/NAD-binding_dom | 2.74e-03 | 57 | 191 | 4 | IPR023753 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 2.80e-03 | 8 | 191 | 2 | IPR004099 | |
| Domain | Chorein_N | 2.80e-03 | 8 | 191 | 2 | PF12624 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 2.80e-03 | 8 | 191 | 2 | IPR016156 | |
| Domain | VPS13_N | 2.80e-03 | 8 | 191 | 2 | IPR026854 | |
| Domain | PDZ | 3.31e-03 | 141 | 191 | 6 | PF00595 | |
| Domain | Copine | 3.57e-03 | 9 | 191 | 2 | PF07002 | |
| Domain | Copine | 3.57e-03 | 9 | 191 | 2 | IPR010734 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 2.89e-13 | 55 | 146 | 12 | M971 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 4.57e-13 | 57 | 146 | 12 | MM15643 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO9 ABCA2 ABCB7 ATP7A ATP7B ATP8A2 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 ATP10B ATP9B ATP2C2 ATP11A ABCC10 ATP8B3 SLC11A2 SLC1A1 ATP10A SLC1A6 ATP10D SLC3A1 ATP2C1 FURIN MTTP SLC24A1 ATP2A2 | 3.05e-10 | 681 | 146 | 28 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO9 ABCA2 ABCB7 ATP7A ATP7B ATP8A2 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 ATP10B ATP9B MFSD4B ATP2C2 ATP11A ABCC10 ATP8B3 SLC11A2 SLC1A1 ATP10A SLC1A6 ATP10D SLC3A1 ATP2C1 FURIN MTTP SLC24A1 ATP2A2 | 3.79e-10 | 736 | 146 | 29 | M27287 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ANO9 ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 3.45e-08 | 176 | 146 | 13 | MM15718 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ANO9 ATP7A ATP7B ATP8A2 ATP10B ATP9B ATP2C2 ATP11A ATP8B3 ATP10A ATP10D ATP2C1 ATP2A2 | 5.47e-08 | 183 | 146 | 13 | M997 |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 8.45e-06 | 99 | 146 | 8 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.13e-05 | 103 | 146 | 8 | M758 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.33e-05 | 76 | 146 | 7 | MM15520 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 NUP205 SLC11A2 SLC1A1 SLC3A1 SLC24A1 | 1.53e-05 | 177 | 146 | 10 | M27476 |
| Pathway | REACTOME_SOMITOGENESIS | 2.13e-05 | 55 | 146 | 6 | M48032 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 3.52e-05 | 60 | 146 | 6 | MM15150 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 4.25e-05 | 62 | 146 | 6 | M39639 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | AUH RIMKLA PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 TXNRD1 DLD KYNU DDO | 4.85e-05 | 245 | 146 | 11 | MM15403 |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 5.09e-05 | 64 | 146 | 6 | M27396 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 5.56e-05 | 65 | 146 | 6 | MM15530 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 6.11e-05 | 96 | 146 | 7 | M27784 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 7.80e-05 | 69 | 146 | 6 | M46439 | |
| Pathway | REACTOME_INTERLEUKIN_1_SIGNALING | 1.02e-04 | 104 | 146 | 7 | MM17224 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 1.33e-04 | 48 | 146 | 5 | MM14528 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 1.44e-04 | 77 | 146 | 6 | MM15698 | |
| Pathway | REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY | 1.62e-04 | 50 | 146 | 5 | MM17068 | |
| Pathway | REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A | 1.62e-04 | 50 | 146 | 5 | MM15385 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 1.62e-04 | 50 | 146 | 5 | M510 | |
| Pathway | REACTOME_INTERLEUKIN_1_SIGNALING | 1.81e-04 | 114 | 146 | 7 | M27895 | |
| Pathway | REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING | 1.82e-04 | 152 | 146 | 8 | M899 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 1.95e-04 | 52 | 146 | 5 | MM15536 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 2.04e-04 | 82 | 146 | 6 | M594 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2 | 2.14e-04 | 53 | 146 | 5 | MM16640 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 2.14e-04 | 53 | 146 | 5 | MM15152 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 2.34e-04 | 54 | 146 | 5 | MM15384 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING | 2.34e-04 | 54 | 146 | 5 | M27931 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 2.49e-04 | 85 | 146 | 6 | MM15041 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 2.55e-04 | 55 | 146 | 5 | M27398 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 2.55e-04 | 55 | 146 | 5 | M27809 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 2.55e-04 | 55 | 146 | 5 | MM15137 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 2.55e-04 | 55 | 146 | 5 | MM15153 | |
| Pathway | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 2.55e-04 | 55 | 146 | 5 | M17095 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 2.55e-04 | 55 | 146 | 5 | M998 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 2.78e-04 | 56 | 146 | 5 | MM15901 | |
| Pathway | REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING | 2.78e-04 | 56 | 146 | 5 | MM15203 | |
| Pathway | REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING | 2.89e-04 | 123 | 146 | 7 | MM15125 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 3.02e-04 | 57 | 146 | 5 | M27399 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 3.02e-04 | 57 | 146 | 5 | M27670 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 3.02e-04 | 57 | 146 | 5 | MM14955 | |
| Pathway | REACTOME_GLI3_IS_PROCESSED_TO_GLI3R_BY_THE_PROTEASOME | 3.02e-04 | 57 | 146 | 5 | MM15205 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 3.19e-04 | 125 | 146 | 7 | M45021 | |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 3.28e-04 | 58 | 146 | 5 | MM14715 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 3.55e-04 | 59 | 146 | 5 | M747 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 3.82e-04 | 92 | 146 | 6 | M27322 | |
| Pathway | REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 3.84e-04 | 60 | 146 | 5 | M1081 | |
| Pathway | REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME | 3.84e-04 | 60 | 146 | 5 | M27470 | |
| Pathway | REACTOME_GASTRULATION | 3.86e-04 | 129 | 146 | 7 | M46433 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 4.05e-04 | 93 | 146 | 6 | MM15204 | |
| Pathway | REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS | 4.15e-04 | 61 | 146 | 5 | M27563 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 4.24e-04 | 131 | 146 | 7 | M5283 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 4.48e-04 | 62 | 146 | 5 | MM15521 | |
| Pathway | REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING | 4.48e-04 | 62 | 146 | 5 | M27465 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 4.48e-04 | 62 | 146 | 5 | MM15181 | |
| Pathway | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | 4.48e-04 | 62 | 146 | 5 | MM14514 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2 | 4.80e-04 | 96 | 146 | 6 | M45026 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 5.03e-04 | 36 | 146 | 4 | M47758 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 5.03e-04 | 36 | 146 | 4 | M47713 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 5.03e-04 | 36 | 146 | 4 | M47714 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 5.03e-04 | 36 | 146 | 4 | M47702 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 5.19e-04 | 64 | 146 | 5 | MM15386 | |
| Pathway | REACTOME_PTEN_REGULATION | 5.36e-04 | 98 | 146 | 6 | MM15348 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 5.58e-04 | 65 | 146 | 5 | M27439 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 5.97e-04 | 100 | 146 | 6 | M27467 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 5.98e-04 | 66 | 146 | 5 | MM15261 | |
| Pathway | REACTOME_PTEN_REGULATION | 6.05e-04 | 139 | 146 | 7 | M27646 | |
| Pathway | REACTOME_HIV_INFECTION | 6.75e-04 | 231 | 146 | 9 | M12469 | |
| Pathway | KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 6.85e-04 | 39 | 146 | 4 | M47701 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 6.87e-04 | 68 | 146 | 5 | M27539 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 6.87e-04 | 68 | 146 | 5 | M27672 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 7.34e-04 | 69 | 146 | 5 | MM15540 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 7.34e-04 | 69 | 146 | 5 | MM15366 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 7.34e-04 | 69 | 146 | 5 | M27815 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 7.34e-04 | 69 | 146 | 5 | MM14522 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 7.55e-04 | 40 | 146 | 4 | M47749 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 7.55e-04 | 40 | 146 | 4 | M47748 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 7.84e-04 | 70 | 146 | 5 | MM15389 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 7.84e-04 | 70 | 146 | 5 | M46438 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 8.12e-04 | 106 | 146 | 6 | M518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 8.30e-04 | 41 | 146 | 4 | M47747 | |
| Pathway | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 8.37e-04 | 71 | 146 | 5 | MM15370 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 8.37e-04 | 71 | 146 | 5 | M4138 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 8.53e-04 | 107 | 146 | 6 | MM14915 | |
| Pathway | REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY | 8.92e-04 | 72 | 146 | 5 | M27802 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 9.49e-04 | 73 | 146 | 5 | MM15491 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 9.49e-04 | 73 | 146 | 5 | MM15285 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 1.01e-03 | 74 | 146 | 5 | MM14678 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 1.01e-03 | 74 | 146 | 5 | M1030 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 1.07e-03 | 75 | 146 | 5 | M641 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.08e-03 | 112 | 146 | 6 | MM15214 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.14e-03 | 76 | 146 | 5 | MM14526 | |
| Pathway | REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | 1.21e-03 | 77 | 146 | 5 | MM14692 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 1.21e-03 | 77 | 146 | 5 | MM14513 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 1.28e-03 | 78 | 146 | 5 | M27473 | |
| Pathway | KEGG_PROTEASOME | 1.29e-03 | 46 | 146 | 4 | M10680 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 CCT3 ACO2 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 CHD4 HNRNPC TXNRD1 FASN PDLIM3 MOV10L1 CPNE3 DLD GCN1 KYNU CAD SELENBP1 DSP CANX HUWE1 PSIP1 TLN1 AKAP13 ATP2A2 NNT HYDIN | 5.40e-15 | 807 | 202 | 29 | 30575818 |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 5.91e-11 | 13 | 202 | 6 | 11015572 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CCT3 BCAS2 ACO2 PSMB4 PSMB6 NARS1 PSMD1 PSMD2 PSMD5 CHD4 RRM1 HNRNPC NUP205 FASN PTPN14 CPNE3 GCN1 SMARCA5 CAD DSP MSH3 HUWE1 TGM1 ZC2HC1A GTF3C2 INF2 TLN1 RTCA AKAP13 ATP2A2 KDM1A | 7.18e-11 | 1353 | 202 | 31 | 29467282 |
| Pubmed | 2.81e-10 | 29 | 202 | 7 | 15071553 | ||
| Pubmed | MPDZ PHAX FASN PTPN14 YAP1 OSBPL11 BOD1L1 TAB1 GCN1 SMARCA5 CAD DSP ATG2B SPECC1L HUWE1 RUFY1 GTF3C2 TLN1 KDM1A | 6.47e-10 | 549 | 202 | 19 | 38280479 | |
| Pubmed | IMPA1 CCT3 ACO2 PSMB4 PSMB6 NARS1 PSMD1 PSMD2 CHD4 HNRNPC FASN PTPN14 YAP1 DLD SEC61A1 GCN1 SMARCA5 CAD SELENBP1 VPS4B CANX SPECC1L HUWE1 ZC2HC1A INF2 TLN1 ATP2A2 KDM1A | 1.03e-09 | 1247 | 202 | 28 | 27684187 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.10e-09 | 4 | 202 | 4 | 10469592 | |
| Pubmed | CCT3 NARS1 PSMD1 PSMD2 CHD4 ME2 WDR43 NUP205 FASN DLD GCN1 SMARCA5 CAD DSP CANX HUWE1 TLN1 ATP2A2 NNT KDM1A | 1.84e-09 | 653 | 202 | 20 | 22586326 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HNRNPCL1 NARS1 PSMD1 PSMD2 CHD4 ITGA2B HNRNPC HNRNPCL3 FASN GCN1 PDLIM2 CANX HUWE1 TLN1 NNT | 2.02e-09 | 344 | 202 | 15 | 30333137 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ABCB7 CCT3 AUH ACO2 PSMB4 PSMB6 PSMD1 PSMD2 ME2 HNRNPC WDR43 PTPN14 OSBPL11 TAB1 SEC61A1 ALDH5A1 MTRF1L CAD CANX FASTKD1 ATG2B RTN4IP1 HUWE1 ARFGEF3 VPS13D GTF3C2 INF2 DNAAF10 ATP2A2 NNT | 3.40e-09 | 1496 | 202 | 30 | 32877691 |
| Pubmed | 4.82e-09 | 12 | 202 | 5 | 21914794 | ||
| Pubmed | 4.82e-09 | 12 | 202 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.50e-09 | 5 | 202 | 4 | 12629516 | |
| Pubmed | CCT3 BCAS2 PSMB4 PSMB6 NARS1 CHD4 PHAX NUP205 TXNRD1 FASN PSMG2 YAP1 CPNE3 CPNE1 BOD1L1 METTL16 KYNU SMARCA5 CAD MSH3 PSIP1 GTF3C2 RTCA KDM1A | 6.56e-09 | 1014 | 202 | 24 | 32416067 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | CCT3 NANP BCAS2 PSMB4 PSMB6 PSMD2 CHD4 RRM1 ME2 NUP205 TXNRD1 FASN CPNE1 DLD SEC61A1 GCN1 ALDH5A1 SMARCA5 DSP CANX HUWE1 TGM1 ZC2HC1A INF2 TLN1 RTCA ATP2A2 NNT | 7.65e-09 | 1367 | 202 | 28 | 32687490 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCT3 BCAS2 C19orf47 PSMD1 PSMD2 CHD4 HNRNPC WDR43 NUP205 FASN CPNE3 HEATR5B GCN1 SMARCA5 CAD DSP CANX SPECC1L HUWE1 PSIP1 TLN1 ATP2A2 NNT KDM1A | 7.91e-09 | 1024 | 202 | 24 | 24711643 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CCT3 BCAS2 PSMD1 PSMD2 CHD4 HNRNPC PARP4 FASN CPNE3 TLN2 GCN1 ARAP1 SMARCA5 DSP SCAF8 HUWE1 TLN1 KDM1A | 1.06e-08 | 582 | 202 | 18 | 20467437 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | CCT3 PSMB4 PSMB6 PSMD1 PSMD2 FASN DLD SEC61A1 GCN1 CAD DSP CANX HUWE1 | 1.23e-08 | 281 | 202 | 13 | 30455355 |
| Pubmed | CCT3 BCAS2 PSMB4 PSMB6 PSMD1 CHD4 FASN PTPN14 GCN1 CAD DSP HUWE1 INF2 TLN1 KDM1A | 1.48e-08 | 399 | 202 | 15 | 37536630 | |
| Pubmed | 1.64e-08 | 6 | 202 | 4 | 25947375 | ||
| Pubmed | ACO2 NARS1 PSMD2 CHD4 RRM1 NUP205 FASN GCN1 CAD CANX ATP2A2 KDM1A | 1.68e-08 | 237 | 202 | 12 | 29564676 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CCT3 ACO2 PSMD1 PSMD2 CHD4 ME2 HNRNPC WDR43 NUP205 FASN DLD TLN2 BOD1L1 SEC61A1 GCN1 SMARCA5 CAD DSP CANX MSH3 HUWE1 PSIP1 GTF3C2 TLN1 RBPJ ATP2A2 NNT KDM1A | 1.85e-08 | 1425 | 202 | 28 | 30948266 |
| Pubmed | ABCA2 ATP7A ATP7B PSMD1 PSMD2 CHD4 NUP205 PARP4 FASN ATP11A HEATR5B GCN1 MUL1 CAD SLC11A2 CANX MSH3 HUWE1 ATP2C1 MAP4K1 FURIN CHD5 AKAP13 NNT SLC37A4 | 2.24e-08 | 1168 | 202 | 25 | 19946888 | |
| Pubmed | 2.82e-08 | 54 | 202 | 7 | 34761751 | ||
| Pubmed | Derlin-1 promotes ubiquitylation and degradation of the epithelial Na+ channel, ENaC. | 3.22e-08 | 55 | 202 | 7 | 28137758 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | CCT3 PSMB4 PSMD2 CHD4 PTPN14 GCN1 SMARCA5 MSH3 HUWE1 GTF3C2 ATP2A2 | 4.98e-08 | 211 | 202 | 11 | 17314511 |
| Pubmed | 7.13e-08 | 37 | 202 | 6 | 35701858 | ||
| Pubmed | CCT3 ACO2 NARS1 PSMD1 PSMD2 KATNAL1 RRM1 CPNE3 OSBPL11 SMARCA5 CAD CANX KATNA1 TGM1 NNT | 7.35e-08 | 451 | 202 | 15 | 36168627 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 8.18e-08 | 94 | 202 | 8 | 21542922 | |
| Pubmed | CCT3 PSMB4 PSMB6 PSMD1 PSMD2 BOD1L1 SEC61A1 SMARCA5 CAD CANX HUWE1 PSIP1 ATP2A2 | 8.98e-08 | 333 | 202 | 13 | 36779763 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TNIK CCT3 BCAS2 NARS1 PSMD5 CHD4 HNRNPC NUP205 FASN CPNE3 SEC61A1 GCN1 SMARCA5 CAD MSH3 HUWE1 RTCA KDM1A | 1.85e-07 | 704 | 202 | 18 | 29955894 |
| Pubmed | RNF121 ABCB7 ATP7A ATP7B IMPA1 CCT3 INPP5B PSMD1 PSMD2 RRM1 MFSD4B HNRNPC NUP205 CPNE3 SEC61A1 CANX ATP2C1 FURIN SLC35F2 ATP2A2 NNT | 1.98e-07 | 952 | 202 | 21 | 38569033 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | PSMD1 RRM1 FASN CPNE3 CPNE1 DLD GCN1 ALPP CANX HUWE1 ATP2C1 TLN1 ATP2A2 NNT | 2.09e-07 | 422 | 202 | 14 | 27342126 |
| Pubmed | 2.26e-07 | 10 | 202 | 4 | 15919184 | ||
| Pubmed | ABCB7 CCT3 PSMD1 PSMD2 CHD4 RRM1 HNRNPC FASN DLD HEATR5B SEC61A1 GCN1 DSP VPS4B CANX HUWE1 INF2 TLN1 ATP2A2 NNT | 2.37e-07 | 878 | 202 | 20 | 37223481 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 PSMB4 MPDZ PSMD1 PSMD2 NUP205 FASN PTPN14 YAP1 CPNE3 TMEM131L DLD TAB1 SEC61A1 GCN1 NRBP1 CANX MTMR8 HUWE1 ATP2C1 KDM1A | 2.88e-07 | 974 | 202 | 21 | 28675297 |
| Pubmed | MON2 ABCB7 CCT3 BCAS2 PSMB4 PSMB6 NARS1 PSMD1 PSMD2 CHD4 RRM1 NUP205 FASN PSMG2 SEC61A1 GCN1 ALPP CAD CANX SPECC1L HUWE1 ARFGEF3 PSIP1 INF2 TLN1 ATP2A2 | 3.22e-07 | 1440 | 202 | 26 | 30833792 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.30e-07 | 202 | 202 | 10 | 33005030 | |
| Pubmed | 4.09e-07 | 79 | 202 | 7 | 14729942 | ||
| Pubmed | CCT3 PSMB4 PSMD1 PSMD2 CHD4 FASN GCN1 CAD DSP CANX ATP2A2 KDM1A | 4.36e-07 | 320 | 202 | 12 | 28685749 | |
| Pubmed | CCT3 ACO2 PSMB4 NARS1 PSMD1 PSMD2 HNRNPC FASN SMARCA5 CAD CANX TGM1 | 5.48e-07 | 327 | 202 | 12 | 31409639 | |
| Pubmed | CCT3 PSMD1 RRM1 HNRNPC NUP205 FASN DLD GCN1 SMARCA5 CAD DSP CANX HUWE1 ATP2A2 | 6.34e-07 | 463 | 202 | 14 | 34901782 | |
| Pubmed | PSMD1 PSMD2 HNRNPC FASN BOD1L1 TAB1 GCN1 SMARCA5 CAD DSP ATP2A2 | 6.36e-07 | 272 | 202 | 11 | 31010829 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | CCT3 NARS1 CHD4 RRM1 FASN BOD1L1 GCN1 MSH3 HUWE1 GTF3C2 TLN1 TTI1 | 6.43e-07 | 332 | 202 | 12 | 32786267 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 6.93e-07 | 219 | 202 | 10 | 31353912 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 23831410 | ||
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 7.69e-07 | 4 | 202 | 3 | 35729324 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 36681355 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 7.69e-07 | 4 | 202 | 3 | 10805751 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 7983737 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HNRNPCL1 CCT3 ACO2 PSMD2 CHD4 HNRNPC WDR43 HNRNPCL3 FASN HNRNPCL4 SEC61A1 SMARCA5 CAD DSP CANX SPECC1L TGM1 PSIP1 CHD5 ATP2A2 | 7.98e-07 | 949 | 202 | 20 | 36574265 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | CCT3 PSMD2 CHD4 HNRNPC FASN GCN1 CAD DSP CANX SPECC1L HUWE1 TLN1 ATP2A2 KIF1C | 9.01e-07 | 477 | 202 | 14 | 31300519 |
| Pubmed | MON2 TNIK SPAST IMPA1 ACO2 PSMB6 PSMD1 PSMD2 LRP1B DLD TLN2 TAB1 GCN1 ALDH5A1 CAD DSP CANX ATG2B HUWE1 ARFGEF3 ATP2C1 ATP2A2 | 9.32e-07 | 1139 | 202 | 22 | 36417873 | |
| Pubmed | ABCA2 CCT3 PSMB4 PSMB6 MPDZ PSMD1 PSMD2 CHD4 PHAX HNRNPC HNRNPCL3 NUP205 FASN CPNE3 DLD SMARCA5 CAD CANX SPECC1L HUWE1 GTF3C2 DNAAF10 ATP2A2 KDM1A | 1.03e-06 | 1335 | 202 | 24 | 29229926 | |
| Pubmed | 1.12e-06 | 58 | 202 | 6 | 19013454 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.14e-06 | 179 | 202 | 9 | 36261009 | |
| Pubmed | HNRNPCL1 CCT3 ACO2 PSMD1 PSMD2 ATP10B CHD4 HNRNPC HNRNPCL3 NUP205 FASN NRXN3 LMLN DLD BOD1L1 ATP11A SEC61A1 SMARCA5 DSP PCDHGA5 PARP8 PSIP1 CHD5 MTTP ATP2A2 | 1.16e-06 | 1442 | 202 | 25 | 35575683 | |
| Pubmed | CCT3 BCAS2 PSMD1 PSMD2 CHD4 RRM1 NUP205 FASN GCN1 SMARCA5 CAD CANX HUWE1 TLN1 ATP2A2 KDM1A | 1.17e-06 | 638 | 202 | 16 | 33239621 | |
| Pubmed | CCT3 AXL PSMB6 PSMD2 FASN CPNE1 SEC61A1 GCN1 ALPP DSP CANX TGM1 TLN1 ATP2A2 | 1.18e-06 | 488 | 202 | 14 | 31324722 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 ABCB7 CCT3 BCAS2 PSMB4 PSMB6 PSMD1 PSMD2 RRM1 HNRNPC NUP205 FASN DLD SEC61A1 GCN1 CAD DSP VPS4B CANX HUWE1 GTF3C2 ATP2A2 KDM1A | 1.30e-06 | 1257 | 202 | 23 | 37317656 |
| Pubmed | CCT3 BCAS2 PSMD1 PSMD2 CHD4 KATNAL1 HNRNPC FASN DLD BOD1L1 TAB1 GCN1 ALDH5A1 CAD DSP CANX CALCOCO1 KDM1A | 1.36e-06 | 809 | 202 | 18 | 32129710 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | CCT3 PSMB4 PSMB6 MPDZ PSMD1 PSMD2 NUP205 FASN CPNE3 SEC61A1 GCN1 CAD CANX HUWE1 ATP2A2 | 1.45e-06 | 571 | 202 | 15 | 37167062 |
| Pubmed | Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. | 1.55e-06 | 96 | 202 | 7 | 34599178 | |
| Pubmed | HNRNPCL1 CCT3 PSMD1 PSMD2 CHD4 HNRNPC NUP205 SMARCA5 DSP CANX TGM1 PSIP1 TLN1 ATP2A2 NNT KDM1A | 1.55e-06 | 652 | 202 | 16 | 31180492 | |
| Pubmed | PSMD1 WDR43 FASN YAP1 OSBPL11 TLN2 NRBP1 SMARCA5 CAD HUWE1 ZC2HC1A GTF3C2 AKAP13 KIF1C | 1.68e-06 | 503 | 202 | 14 | 16964243 | |
| Pubmed | MON2 RNF121 ATP7A ATP7B OSBPL11 TMEM131L HEATR5B ATG2B SLC1A1 ARFGEF3 VPS13D INF2 TRAPPC12 FURIN | 1.72e-06 | 504 | 202 | 14 | 34432599 | |
| Pubmed | 1.77e-06 | 35 | 202 | 5 | 16857966 | ||
| Pubmed | 1.84e-06 | 63 | 202 | 6 | 19193609 | ||
| Pubmed | 1.84e-06 | 244 | 202 | 10 | 28902428 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 29846695 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 26567335 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 1.91e-06 | 5 | 202 | 3 | 25809670 | |
| Pubmed | 2.16e-06 | 144 | 202 | 8 | 35681168 | ||
| Pubmed | 2.36e-06 | 37 | 202 | 5 | 8811196 | ||
| Pubmed | Hypermutation of HIV-1 DNA in the absence of the Vif protein. | 2.36e-06 | 37 | 202 | 5 | 12750511 | |
| Pubmed | 2.36e-06 | 37 | 202 | 5 | 9811770 | ||
| Pubmed | Evidence for a newly discovered cellular anti-HIV-1 phenotype. | 2.36e-06 | 37 | 202 | 5 | 9846577 | |
| Pubmed | 2.36e-06 | 37 | 202 | 5 | 12840737 | ||
| Pubmed | 2.36e-06 | 37 | 202 | 5 | 12719574 | ||
| Pubmed | Death by deamination: a novel host restriction system for HIV-1. | 2.36e-06 | 37 | 202 | 5 | 12914693 | |
| Pubmed | 2.36e-06 | 37 | 202 | 5 | 12830140 | ||
| Pubmed | 2.42e-06 | 312 | 202 | 11 | 37120454 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK CCT3 NANP CHD4 PHAX ME2 WDR43 FASN PDLIM3 CPNE3 OSBPL11 DLD BOD1L1 GCN1 SMARCA5 DSP ATG2B PSIP1 TLN1 | 2.55e-06 | 934 | 202 | 19 | 33916271 |
| Pubmed | The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. | 2.70e-06 | 38 | 202 | 5 | 12808465 | |
| Pubmed | 2.70e-06 | 38 | 202 | 5 | 12808466 | ||
| Pubmed | 2.70e-06 | 38 | 202 | 5 | 14527406 | ||
| Pubmed | DNA deamination mediates innate immunity to retroviral infection. | 2.70e-06 | 38 | 202 | 5 | 12809610 | |
| Pubmed | The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. | 2.70e-06 | 38 | 202 | 5 | 14614829 | |
| Pubmed | 2.70e-06 | 38 | 202 | 5 | 12920286 | ||
| Pubmed | 2.70e-06 | 38 | 202 | 5 | 12970355 | ||
| Pubmed | 2.70e-06 | 38 | 202 | 5 | 10893419 | ||
| Pubmed | 2.70e-06 | 38 | 202 | 5 | 14557625 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CCT3 BCAS2 PSMB6 NARS1 PSMD1 PSMD2 CHD4 RRM1 HNRNPC TXNRD1 FASN GCN1 SMARCA5 CAD DSP SCAF8 CANX HUWE1 PSIP1 DNAAF10 TLN1 AKAP13 ATP2A2 KIF1C | 2.80e-06 | 1415 | 202 | 24 | 28515276 |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | PSMB4 PSMB6 PSMD1 PSMD2 HNRNPC WDR43 SEC61A1 SMARCA5 DSP CANX SLC1A1 PSIP1 SLC35F2 ATP2A2 NNT | 2.87e-06 | 604 | 202 | 15 | 37616343 |
| Pubmed | HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. | 3.08e-06 | 39 | 202 | 5 | 14528301 | |
| Pubmed | 3.14e-06 | 259 | 202 | 10 | 31162944 | ||
| Pubmed | 3.17e-06 | 18 | 202 | 4 | 18664271 | ||
| Pubmed | PSMB4 PSMB6 PSMD1 CHD4 NUP205 FASN CPNE3 TAB1 GCN1 ALDH5A1 CAD CANX HUWE1 NNT | 3.35e-06 | 534 | 202 | 14 | 35032548 | |
| Pubmed | The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. | 3.51e-06 | 40 | 202 | 5 | 14528300 | |
| Interaction | AGR2 interactions | ABCA2 CCT3 ACO2 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 CHD4 HNRNPC TXNRD1 FASN PDLIM3 MOV10L1 CPNE3 DLD GCN1 KYNU CAD SELENBP1 DSP CANX HUWE1 PSIP1 TLN1 AKAP13 ATP2A2 NNT HYDIN | 3.50e-08 | 934 | 197 | 29 | int:AGR2 |
| Interaction | CLEC2D interactions | ABCA2 ABCB7 ATP7A ATP7B HNRNPC TMEM131L CANX NLRX1 FASTKD1 ARFGEF3 SYT15 ATP2C1 | 5.70e-07 | 197 | 197 | 12 | int:CLEC2D |
| Interaction | MOB3C interactions | CCT3 BCAS2 PSMB4 PSMB6 PSMD1 CHD4 FASN PTPN14 GCN1 CAD DSP HUWE1 INF2 TLN1 KDM1A | 3.15e-06 | 364 | 197 | 15 | int:MOB3C |
| Interaction | CDC34 interactions | ACO2 NARS1 PSMD2 CHD4 RRM1 NUP205 FASN GCN1 MUL1 CAD CANX HUWE1 ATP2A2 KDM1A | 4.53e-06 | 328 | 197 | 14 | int:CDC34 |
| Interaction | RITA1 interactions | 7.97e-06 | 49 | 197 | 6 | int:RITA1 | |
| Interaction | PSMB8 interactions | 8.97e-06 | 105 | 197 | 8 | int:PSMB8 | |
| Interaction | EPRS1 interactions | ABCB7 SPAST AXL ACO2 NARS1 PSMD2 CHD4 HNRNPC FASN YAP1 DLD TAB1 CAD DSP CANX HUWE1 RUFY1 | 1.25e-05 | 513 | 197 | 17 | int:EPRS1 |
| Interaction | ARRDC4 interactions | 1.70e-05 | 83 | 197 | 7 | int:ARRDC4 | |
| Interaction | ARHGAP24 interactions | CCT3 ACO2 NARS1 PSMD1 PSMD2 KATNAL1 RRM1 CPNE3 OSBPL11 DLD SMARCA5 CAD CANX KATNA1 TGM1 NNT | 2.46e-05 | 486 | 197 | 16 | int:ARHGAP24 |
| Interaction | CCDC8 interactions | CCT3 C19orf47 PSMD1 PSMD2 CHD4 NUP205 FASN CPNE3 HEATR5B GCN1 SMARCA5 CAD DSP CANX SPECC1L HUWE1 RHOH ATP2A2 NNT | 2.51e-05 | 656 | 197 | 19 | int:CCDC8 |
| Interaction | VCP interactions | MON2 SPAST IMPA1 CCT3 ACO2 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 HNRNPC WDR43 NUP205 TXNRD1 YAP1 DLD SEC61A1 ALDH5A1 MUL1 VCPKMT SMARCA5 CAD DSP VPS4B CANX HUWE1 RHOH VPS13D INF2 ATP2A2 NNT | 2.52e-05 | 1435 | 197 | 31 | int:VCP |
| Interaction | CUL7 interactions | CCT3 PSMB4 PSMD2 CHD4 HNRNPC WDR43 NUP205 FASN SEC61A1 GCN1 PLXNB3 SMARCA5 CAD DSP CANX MSH3 PSIP1 MAP4K1 TLN1 ATP2A2 NNT KIF1C | 2.89e-05 | 845 | 197 | 22 | int:CUL7 |
| Interaction | SDHA interactions | AUH ACO2 PSMD1 PSMD2 FASN CPNE3 CPNE1 DLD GCN1 MTRF1L DSP CANX RUFY1 MAP4K1 NNT | 2.90e-05 | 439 | 197 | 15 | int:SDHA |
| Interaction | ISG15 interactions | SPAST CCT3 PSMB4 PSMB6 PSMD1 PSMD2 NUP205 TXNRD1 FASN UBA7 TAB1 GCN1 CAD CANX SPECC1L ATP2A2 | 3.00e-05 | 494 | 197 | 16 | int:ISG15 |
| Interaction | TMEM41B interactions | 3.17e-05 | 162 | 197 | 9 | int:TMEM41B | |
| Interaction | LRRC31 interactions | 3.52e-05 | 205 | 197 | 10 | int:LRRC31 | |
| Interaction | PSME4 interactions | 4.10e-05 | 95 | 197 | 7 | int:PSME4 | |
| Interaction | KCNA3 interactions | IL16 ATP7A CCT3 LAMA1 NARS1 MPDZ PSMD1 PSMD2 RRM1 FASN TLN2 BOD1L1 SEC61A1 GCN1 CAD DSP CANX ATG2B SPECC1L SLC1A1 TLN1 ATP2A2 | 4.54e-05 | 871 | 197 | 22 | int:KCNA3 |
| Interaction | PSMD13 interactions | PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 FASN PSMG2 YAP1 DLD CAD HUWE1 RUFY1 | 5.04e-05 | 306 | 197 | 12 | int:PSMD13 |
| Interaction | FBXO42 interactions | MON2 CCT3 FASN PTPN14 TAB1 CAD DSP RUFY1 ARFGEF3 RBPJ ATP2A2 | 5.10e-05 | 259 | 197 | 11 | int:FBXO42 |
| Interaction | LOXL2 interactions | CCT3 ACO2 PSMB4 NARS1 PSMD1 PSMD2 HNRNPC FASN ALPP SMARCA5 CAD WNT7A CANX TGM1 | 5.42e-05 | 410 | 197 | 14 | int:LOXL2 |
| Interaction | PSMA4 interactions | CCT3 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 TXNRD1 FASN PSMG2 YAP1 DSP HUWE1 | 5.71e-05 | 310 | 197 | 12 | int:PSMA4 |
| Interaction | HNRNPCL3 interactions | 6.78e-05 | 23 | 197 | 4 | int:HNRNPCL3 | |
| Interaction | YAP1 interactions | HNRNPCL1 CCT3 PSMB4 MPDZ PSMD2 CHD4 PHAX HNRNPC FASN PTPN14 YAP1 CPNE3 DLD BOD1L1 TAB1 GCN1 SMARCA5 CAD DSP VPS4B HUWE1 TGM1 GTF3C2 TLN1 KDM1A | 6.97e-05 | 1095 | 197 | 25 | int:YAP1 |
| Interaction | PTPRM interactions | 7.39e-05 | 72 | 197 | 6 | int:PTPRM | |
| Interaction | CCT8L1P interactions | 7.40e-05 | 9 | 197 | 3 | int:CCT8L1P | |
| Interaction | PSMC3 interactions | PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 FASN PSMG2 YAP1 DLD TAB1 CAD HUWE1 RUFY1 KDM1A | 7.95e-05 | 425 | 197 | 14 | int:PSMC3 |
| Interaction | PPP6C interactions | 8.60e-05 | 228 | 197 | 10 | int:PPP6C | |
| Interaction | HUWE1 interactions | TNIK CCT3 ACO2 PSMB4 PSMB6 PSMD1 PSMD2 PHAX NUP205 FAP FASN YAP1 CPNE3 DLD SEC61A1 GCN1 SMARCA5 CAD CANX HUWE1 RUFY1 FURIN ATP2A2 NNT KDM1A | 8.66e-05 | 1110 | 197 | 25 | int:HUWE1 |
| Interaction | PAAF1 interactions | 1.00e-04 | 76 | 197 | 6 | int:PAAF1 | |
| Interaction | GRM2 interactions | CCT3 PSMB4 PSMB6 PSMD1 PSMD2 BOD1L1 SEC61A1 SMARCA5 CAD CANX HUWE1 PSIP1 ATP2A2 | 1.01e-04 | 381 | 197 | 13 | int:GRM2 |
| Interaction | TMEM9B interactions | 1.10e-04 | 111 | 197 | 7 | int:TMEM9B | |
| Interaction | ATXN3 interactions | CCT3 PSMB4 PSMB6 PSMD1 PSMD2 FASN YAP1 DLD SEC61A1 GCN1 CAD DSP CANX HUWE1 | 1.12e-04 | 439 | 197 | 14 | int:ATXN3 |
| Interaction | PTEN interactions | CCT3 ACO2 PSMD2 CHD4 HNRNPC FSIP2 TTBK2 FASN PTPN14 YAP1 DLD METTL16 SEC61A1 SMARCA5 CAD DSP GTF3C2 INF2 AKAP13 ATP2A2 NNT KDM1A | 1.16e-04 | 929 | 197 | 22 | int:PTEN |
| Interaction | HLA-B interactions | MON2 ABCA2 ABCB7 PSMD1 NUP205 GCN1 CANX FASTKD1 HUWE1 SLC1A1 | 1.27e-04 | 239 | 197 | 10 | int:HLA-B |
| Interaction | PINK1 interactions | CCT3 PSMD1 PSMD2 CHD4 HNRNPC FASN YAP1 GCN1 CAD DSP CANX NLRX1 SPECC1L HUWE1 TGM1 TLN1 ATP2A2 KIF1C | 1.27e-04 | 679 | 197 | 18 | int:PINK1 |
| Interaction | PSMD3 interactions | BCAS2 PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 ITGA2B FASN DLD NRBP1 CAD HUWE1 RUFY1 | 1.28e-04 | 390 | 197 | 13 | int:PSMD3 |
| Interaction | SIRT7 interactions | CCT3 NARS1 PSMD1 PSMD2 CHD4 ME2 WDR43 NUP205 FASN DLD GCN1 CAD DSP CANX HUWE1 TLN1 ATP2A2 NNT KDM1A | 1.33e-04 | 744 | 197 | 19 | int:SIRT7 |
| Interaction | SNW1 interactions | HNRNPCL1 CCT3 BCAS2 PSMD1 PSMD2 CHD4 HNRNPC FASN YAP1 CPNE3 GCN1 ARAP1 SMARCA5 DSP SPECC1L HUWE1 TLN1 RBPJ MTTP | 1.41e-04 | 747 | 197 | 19 | int:SNW1 |
| Interaction | SCPEP1 interactions | 1.43e-04 | 81 | 197 | 6 | int:SCPEP1 | |
| Interaction | SMARCAD1 interactions | 1.43e-04 | 197 | 197 | 9 | int:SMARCAD1 | |
| Interaction | PSMC6 interactions | PSMB4 PSMB6 PSMD1 PSMD2 PSMD5 CHD4 YAP1 DLD SEC61A1 CAD HUWE1 RUFY1 | 1.45e-04 | 342 | 197 | 12 | int:PSMC6 |
| Interaction | ADNP interactions | 1.54e-04 | 199 | 197 | 9 | int:ADNP | |
| Interaction | DDX39B interactions | CCT3 ACO2 C19orf47 CHD4 PHAX HNRNPC FASN YAP1 DLD TAB1 ALPP CAD DSP SPECC1L HUWE1 TGM1 | 1.60e-04 | 570 | 197 | 16 | int:DDX39B |
| Interaction | MBD2 interactions | 1.90e-04 | 161 | 197 | 8 | int:MBD2 | |
| Interaction | WDR5 interactions | CCT3 BCAS2 ACO2 NARS1 PSMD1 PSMD2 CHD4 PHAX HNRNPC NUP205 FASN YAP1 CPNE1 BOD1L1 METTL16 GCN1 SMARCA5 DSP CANX ZC2HC1A PSIP1 TLN1 ATP2A2 KDM1A | 1.98e-04 | 1101 | 197 | 24 | int:WDR5 |
| Interaction | SEM1 interactions | 1.98e-04 | 162 | 197 | 8 | int:SEM1 | |
| Interaction | SLC1A4 interactions | 1.99e-04 | 30 | 197 | 4 | int:SLC1A4 | |
| Interaction | METTL23 interactions | 1.99e-04 | 30 | 197 | 4 | int:METTL23 | |
| Interaction | IDH3A interactions | 2.06e-04 | 163 | 197 | 8 | int:IDH3A | |
| Interaction | POU5F1 interactions | CCT3 LAMA1 PSMB6 PSMD2 CHD4 GCN1 SMARCA5 CAD SCAF8 HUWE1 PSIP1 GTF3C2 CHD5 RBPJ TTI1 KDM1A | 2.10e-04 | 584 | 197 | 16 | int:POU5F1 |
| Interaction | PSMA6 interactions | CCT3 PSMB4 PSMB6 C19orf47 PSMD1 PSMD2 PSMD5 PSMG2 BOD1L1 CANX HUWE1 | 2.16e-04 | 305 | 197 | 11 | int:PSMA6 |
| Interaction | DDI2 interactions | 2.20e-04 | 124 | 197 | 7 | int:DDI2 | |
| Interaction | KLRB1 interactions | 2.35e-04 | 57 | 197 | 5 | int:KLRB1 | |
| Interaction | PSMB9 interactions | 2.40e-04 | 89 | 197 | 6 | int:PSMB9 | |
| Interaction | SUMO2 interactions | CCT3 ACO2 NARS1 CHD4 RRM1 FASN BOD1L1 GCN1 CAD SELENBP1 MSH3 HUWE1 GTF3C2 TLN1 TTI1 KDM1A | 2.40e-04 | 591 | 197 | 16 | int:SUMO2 |
| Interaction | WIPI2 interactions | 2.55e-04 | 90 | 197 | 6 | int:WIPI2 | |
| Interaction | PSMA2 interactions | 2.66e-04 | 214 | 197 | 9 | int:PSMA2 | |
| Interaction | PSMB4 interactions | 2.66e-04 | 214 | 197 | 9 | int:PSMB4 | |
| Interaction | WWTR1 interactions | IL16 MPDZ PTPN14 YAP1 OSBPL11 GCN1 SMARCA5 ATG2B RTN4IP1 SPECC1L RUFY1 GTF3C2 TLN1 | 2.75e-04 | 422 | 197 | 13 | int:WWTR1 |
| Interaction | PRSS53 interactions | 2.83e-04 | 3 | 197 | 2 | int:PRSS53 | |
| Interaction | ATP2C2 interactions | 2.83e-04 | 3 | 197 | 2 | int:ATP2C2 | |
| Interaction | PEX3 interactions | 2.86e-04 | 171 | 197 | 8 | int:PEX3 | |
| Interaction | ADRM1 interactions | 3.01e-04 | 266 | 197 | 10 | int:ADRM1 | |
| Interaction | JUP interactions | AXL NARS1 CHD4 FASN PTPN14 YAP1 DLD CAD DSP VPS4B RHOH TLN1 SLC35F2 KDM1A | 3.12e-04 | 485 | 197 | 14 | int:JUP |
| Interaction | SPAG9 interactions | 3.19e-04 | 268 | 197 | 10 | int:SPAG9 | |
| Interaction | SHMT2 interactions | CCT3 AUH ACO2 MPDZ DGKQ ME2 NUP205 TXNRD1 DLD TAB1 MTRF1L SCAF8 CANX NT5C3B HUWE1 TLN1 NNT | 3.33e-04 | 671 | 197 | 17 | int:SHMT2 |
| Interaction | NUP107 interactions | 3.36e-04 | 221 | 197 | 9 | int:NUP107 | |
| Interaction | PSME2 interactions | 3.38e-04 | 133 | 197 | 7 | int:PSME2 | |
| Interaction | STIP1 interactions | CCT3 BCAS2 PSMD1 PSMD2 CHD4 RRM1 NUP205 TXNRD1 FASN PTPN14 YAP1 DLD GCN1 SMARCA5 CAD CANX MTMR8 HUWE1 MAP4K1 TLN1 ATP2A2 KDM1A | 3.54e-04 | 1006 | 197 | 22 | int:STIP1 |
| Interaction | ZNF598 interactions | CCT3 PSMB4 PSMD1 PSMD2 CHD4 FASN GCN1 CAD DSP CANX TGM1 ATP2A2 KDM1A | 3.68e-04 | 435 | 197 | 13 | int:ZNF598 |
| Interaction | RCOR1 interactions | TNIK PSMD1 CHD4 FASN GCN1 SMARCA5 DSP VPS4B ATG2B HUWE1 RUFY1 B9D2 RBPJ KDM1A | 3.75e-04 | 494 | 197 | 14 | int:RCOR1 |
| Interaction | DHTKD1 interactions | 3.77e-04 | 63 | 197 | 5 | int:DHTKD1 | |
| Interaction | HNRNPCL2 interactions | HNRNPCL1 CHD4 LRP1B HNRNPC WDR43 HNRNPCL3 FASN SMARCA5 GTF3C2 RTCA | 3.80e-04 | 274 | 197 | 10 | int:HNRNPCL2 |
| Interaction | KPNA4 interactions | 3.84e-04 | 225 | 197 | 9 | int:KPNA4 | |
| Interaction | P2RY8 interactions | 3.88e-04 | 179 | 197 | 8 | int:P2RY8 | |
| Interaction | LDHB interactions | 3.91e-04 | 327 | 197 | 11 | int:LDHB | |
| Interaction | VTA1 interactions | 4.04e-04 | 137 | 197 | 7 | int:VTA1 | |
| Interaction | NRBP2 interactions | 4.05e-04 | 64 | 197 | 5 | int:NRBP2 | |
| Interaction | LPAR4 interactions | 4.08e-04 | 36 | 197 | 4 | int:LPAR4 | |
| Interaction | PDHA1 interactions | ABCB7 AUH ACO2 CHD4 ME2 FASN DLD MTRF1L SMARCA5 DSP CANX FASTKD1 RTN4IP1 HUWE1 MAP4K1 FURIN ATP2A2 NNT | 4.24e-04 | 750 | 197 | 18 | int:PDHA1 |
| Interaction | ITM2C interactions | 4.26e-04 | 99 | 197 | 6 | int:ITM2C | |
| Interaction | F2RL1 interactions | 4.34e-04 | 182 | 197 | 8 | int:F2RL1 | |
| Interaction | POMP interactions | 4.36e-04 | 65 | 197 | 5 | int:POMP | |
| Interaction | WWOX interactions | HNRNPCL1 AXL MPDZ PSMD1 FASN PTPN14 DLD SEC61A1 GCN1 CAD DSP SCAF8 CANX HUWE1 ATP2A2 KDM1A | 4.61e-04 | 627 | 197 | 16 | int:WWOX |
| Interaction | H2BC9 interactions | LAMA1 CHD4 FSIP2 PARP4 SMARCA5 DSP BAZ2B MSH3 SPECC1L RUFY1 RHOH PSIP1 KDM1A | 4.66e-04 | 446 | 197 | 13 | int:H2BC9 |
| Interaction | NNT interactions | 4.84e-04 | 185 | 197 | 8 | int:NNT | |
| GeneFamily | ATPase phospholipid transporting | 7.14e-12 | 15 | 136 | 7 | 1210 | |
| GeneFamily | Proteasome | 1.71e-05 | 43 | 136 | 5 | 690 | |
| GeneFamily | ATPases Ca2+ transporting | 3.38e-05 | 9 | 136 | 3 | 1209 | |
| GeneFamily | ATPase copper transporting | 5.62e-05 | 2 | 136 | 2 | 1212 | |
| GeneFamily | AAA ATPases | 6.74e-04 | 53 | 136 | 4 | 413 | |
| GeneFamily | PDZ domain containing | 1.02e-03 | 152 | 136 | 6 | 1220 | |
| GeneFamily | Phosphoinositide phosphatases | 1.76e-03 | 32 | 136 | 3 | 1079 | |
| GeneFamily | Copines | 1.95e-03 | 9 | 136 | 2 | 829 | |
| GeneFamily | HAD Asp-based non-protein phosphatases | 2.95e-03 | 11 | 136 | 2 | 1045 | |
| GeneFamily | Paraneoplastic Ma antigens | 2.95e-03 | 11 | 136 | 2 | 671 | |
| GeneFamily | Solute carriers | SLC35G5 SLC49A3 SLC11A2 SLC1A1 SLC1A6 SLC3A1 SLC35F2 SLC24A1 SLC37A4 | 3.03e-03 | 395 | 136 | 9 | 752 |
| GeneFamily | PHD finger proteins|NuRD complex | 3.53e-03 | 12 | 136 | 2 | 1305 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ATP7A ATP7B IMPA1 CCT3 ACO2 PSMD1 PSMD2 ITGA2B HNRNPC TXNRD1 FZD7 FASN PSMG2 CPNE3 DLD ALDH5A1 KYNU SMARCA5 CAD VPS4B CANX KATNA1 RHOH ATP2C1 PSIP1 RTCA RBPJ ATP2A2 NNT SLC37A4 | 1.36e-07 | 1399 | 193 | 30 | M535 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.77e-05 | 250 | 193 | 10 | M11318 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP | 1.85e-05 | 200 | 193 | 9 | M4790 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN | 1.85e-05 | 200 | 193 | 9 | M8600 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN | 1.85e-05 | 200 | 193 | 9 | M5212 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SPAST AUH ME2 KLHL20 WDR43 TXNRD1 YAP1 TMEM131L SMARCA5 SLC11A2 SASH1 BAZ2B SCAF8 MSH3 SPECC1L ATP2C1 GTF3C2 RBPJ AKAP13 | 2.02e-05 | 856 | 193 | 19 | M4500 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 3.06e-05 | 164 | 193 | 8 | M13108 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | ABCA2 ATP7B CHD4 PARP4 ABCC10 CAD SELENBP1 TRAPPC12 ATP2A2 SLC37A4 | 4.10e-05 | 276 | 193 | 10 | M3063 |
| ToppCell | AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.27e-07 | 198 | 194 | 9 | 8a1f984e46f4fa5be33027b9dbaa2ca060a2245d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 181 | 194 | 8 | c1b1e62440805800a3a600b1ddd79be1c9762598 | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 2.08e-06 | 192 | 194 | 8 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-06 | 194 | 194 | 8 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-06 | 194 | 194 | 8 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 56 | 194 | 5 | 55337ff90621e1fea4d747ae2559c0fa61b38dce | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.65e-06 | 160 | 194 | 7 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 175 | 194 | 7 | b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 175 | 194 | 7 | 067c7d89cfdf6ebf70692df64b9b79d752f093dd | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.28e-05 | 177 | 194 | 7 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-05 | 181 | 194 | 7 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 186 | 194 | 7 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-05 | 189 | 194 | 7 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 191 | 194 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-05 | 191 | 194 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 191 | 194 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 191 | 194 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.10e-05 | 191 | 194 | 7 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-05 | 191 | 194 | 7 | f00d6824bd138b192a996e9f7de57b235bb24c18 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.17e-05 | 192 | 194 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 2.17e-05 | 192 | 194 | 7 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 2.17e-05 | 192 | 194 | 7 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 194 | 194 | 7 | c422aeddb4e949a22f731da675bdf91dee86ba61 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 194 | 194 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.40e-05 | 195 | 194 | 7 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 195 | 194 | 7 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 195 | 194 | 7 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 195 | 194 | 7 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 195 | 194 | 7 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.40e-05 | 195 | 194 | 7 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 196 | 194 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.48e-05 | 196 | 194 | 7 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 196 | 194 | 7 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.73e-05 | 199 | 194 | 7 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 200 | 194 | 7 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.82e-05 | 200 | 194 | 7 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 194 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 200 | 194 | 7 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 200 | 194 | 7 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 200 | 194 | 7 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 194 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.82e-05 | 200 | 194 | 7 | 8472baa74c48b67c5f08223025885c833458290b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 5.08e-05 | 150 | 194 | 6 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-05 | 159 | 194 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-05 | 159 | 194 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Scn4b_(Globus_Pallidus_Externus_(GP),_"Prototypical")--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 51 | 194 | 4 | 74d7932d0e7363c00117890747980b4b04ff4524 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Scn4b_(Globus_Pallidus_Externus_(GP),_"Prototypical")-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 51 | 194 | 4 | 88597bef58fe807b65da34925e863e7fbe3a7e3e | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Scn4b_(Globus_Pallidus_Externus_(GP),_"Prototypical")|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 51 | 194 | 4 | 91e17b1a85e2b5c507c64f39f322a5a9b7bf30bd | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-05 | 161 | 194 | 6 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-05 | 161 | 194 | 6 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.53e-05 | 161 | 194 | 6 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 162 | 194 | 6 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 8.33e-05 | 164 | 194 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.80e-05 | 103 | 194 | 5 | d8965b338b90ddc0686ea0d94e9a330128566c39 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 166 | 194 | 6 | 829a8998ce68739a58202851afd73e049ab0f84f | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 166 | 194 | 6 | c43aec09578975df8984886993d15b42a10190c8 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.51e-05 | 168 | 194 | 6 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.83e-05 | 169 | 194 | 6 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.83e-05 | 169 | 194 | 6 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 1.02e-04 | 170 | 194 | 6 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 171 | 194 | 6 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.08e-04 | 172 | 194 | 6 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 172 | 194 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.08e-04 | 172 | 194 | 6 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 173 | 194 | 6 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 173 | 194 | 6 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 174 | 194 | 6 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 174 | 194 | 6 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.23e-04 | 176 | 194 | 6 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 177 | 194 | 6 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 194 | 6 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 194 | 6 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 179 | 194 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 180 | 194 | 6 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 180 | 194 | 6 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 114 | 194 | 5 | 2cc5d2da5573650c5232a01e2d2128082c4bffcb | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 114 | 194 | 5 | fceb7cc590a47380145fc0d854c9f2350dbb0a59 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 182 | 194 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 182 | 194 | 6 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-04 | 182 | 194 | 6 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 182 | 194 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 183 | 194 | 6 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.56e-04 | 184 | 194 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 184 | 194 | 6 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 185 | 194 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 186 | 194 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.66e-04 | 186 | 194 | 6 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.66e-04 | 186 | 194 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 194 | 6 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 187 | 194 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 187 | 194 | 6 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| Drug | hydroxyl radicals | ATP7A ATP7B IMPA1 AUH ACO2 ATP9B KATNAL1 RRM1 ME2 LRP1B DPM2 GGT5 FASN UBA7 PTPN14 ATP2C2 DLD ATP11A ALDH5A1 KYNU ALPP ATP8B3 COL6A3 CAD DDO KATNA1 ATP10D TGM1 ATP2C1 ARSA ATP2A2 SLC37A4 | 1.04e-07 | 1341 | 193 | 32 | CID000000961 |
| Drug | aspartate | ABCB7 ACO2 NARS1 BACE1 ME2 GGT5 DLD ALDH5A1 KYNU ALPP CAD DDO REN SLC1A1 SLC1A6 SLC3A1 FURIN SLC37A4 | 4.81e-07 | 518 | 193 | 18 | CID000000424 |
| Drug | oxalate | 1.02e-06 | 158 | 193 | 10 | CID000000971 | |
| Drug | dithiotreitol | IMPA1 LAMA1 RRM1 ME2 ATP2C2 DLD METTL16 CANX REN POSTN TGM1 ATP2C1 DNAAF10 ATP2A2 NNT | 4.29e-06 | 430 | 193 | 15 | CID000019001 |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | ATP9B KLHL20 ATP11A MUL1 PDLIM2 KYNU NLRX1 VPS13D INF2 AKAP13 | 7.41e-06 | 197 | 193 | 10 | 1282_UP |
| Drug | SureCN1562346 | 8.13e-06 | 33 | 193 | 5 | CID011646228 | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 2.67e-07 | 3 | 191 | 3 | DOID:0070221 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | ABCB7 SUSD6 C19orf47 CHD4 RRM1 NUP205 TMEM131L CPNE1 TLN2 TMUB2 ABCC10 CAD PCDHGA5 NLRX1 SPECC1L RHD AKAP13 | 1.92e-05 | 799 | 191 | 17 | EFO_0010701 |
| Disease | idiopathic pulmonary fibrosis | 3.44e-05 | 57 | 191 | 5 | EFO_0000768 | |
| Disease | occipital horn syndrome (implicated_via_orthology) | 4.17e-05 | 2 | 191 | 2 | DOID:0111272 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.30e-04 | 40 | 191 | 4 | C0598589 | |
| Disease | chronic obstructive pulmonary disease, interleukin-8 measurement | 2.48e-04 | 4 | 191 | 2 | EFO_0000341, EFO_0004811 | |
| Disease | familial juvenile hyperuricemic nephropathy (is_implicated_in) | 2.48e-04 | 4 | 191 | 2 | DOID:0060062 (is_implicated_in) | |
| Disease | metal metabolism disorder (implicated_via_orthology) | 2.48e-04 | 4 | 191 | 2 | DOID:896 (implicated_via_orthology) | |
| Disease | orofacial cleft (implicated_via_orthology) | 2.48e-04 | 4 | 191 | 2 | DOID:0050567 (implicated_via_orthology) | |
| Disease | Familial juvenile gout | 2.48e-04 | 4 | 191 | 2 | cv:C0268113 | |
| Disease | Malignant neoplasm of ovary | 2.77e-04 | 137 | 191 | 6 | C1140680 | |
| Disease | Wilson disease (implicated_via_orthology) | 4.12e-04 | 5 | 191 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Neurologic Symptoms | 4.12e-04 | 5 | 191 | 2 | C0235031 | |
| Disease | Neurological observations | 4.12e-04 | 5 | 191 | 2 | C0422837 | |
| Disease | Neurologic Manifestations | 4.12e-04 | 5 | 191 | 2 | C0027854 | |
| Disease | Menkes disease (implicated_via_orthology) | 4.12e-04 | 5 | 191 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | Neurologic Dysfunction | 4.12e-04 | 5 | 191 | 2 | C0751377 | |
| Disease | Neurologic Signs | 4.12e-04 | 5 | 191 | 2 | C0751378 | |
| Disease | Focal Neurologic Deficits | 4.12e-04 | 5 | 191 | 2 | C0746857 | |
| Disease | Nephritis, Interstitial | 4.89e-04 | 24 | 191 | 3 | C0027707 | |
| Disease | Neurologic Deficits | 6.15e-04 | 6 | 191 | 2 | C0521654 | |
| Disease | hypertensive nephropathy | 6.15e-04 | 6 | 191 | 2 | C0848548 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 6.15e-04 | 6 | 191 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 6.15e-04 | 6 | 191 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ATP7B BCAS2 LAMA1 SPNS3 TXNRD1 YAP1 CAD SLC11A2 SELENBP1 PARP8 POSTN P2RX7 CHD5 | 6.98e-04 | 702 | 191 | 13 | C0009402 |
| Disease | hair colour measurement | TNIK IL16 AXL MFSD4B FZD7 PTPN14 NRBP1 SASH1 PARP8 ATP10A ANGPTL2 AKAP13 | 7.13e-04 | 615 | 191 | 12 | EFO_0007822 |
| Disease | trauma exposure measurement | 9.21e-04 | 172 | 191 | 6 | EFO_0010703 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.46e-03 | 9 | 191 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | chronic fatigue syndrome (is_marker_for) | 1.81e-03 | 10 | 191 | 2 | DOID:8544 (is_marker_for) | |
| Disease | ovarian neoplasm | 1.84e-03 | 134 | 191 | 5 | C0919267 | |
| Disease | Colorectal Neoplasms | 2.27e-03 | 277 | 191 | 7 | C0009404 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.59e-03 | 145 | 191 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | endometrial carcinoma (is_implicated_in) | 2.64e-03 | 12 | 191 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | amygdala volume | 3.10e-03 | 13 | 191 | 2 | EFO_0006934 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 3.10e-03 | 13 | 191 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Neuroblastoma | 3.51e-03 | 47 | 191 | 3 | C0027819 | |
| Disease | Hamman-Rich syndrome | 3.60e-03 | 14 | 191 | 2 | C0085786 | |
| Disease | Generalized seizures | 4.26e-03 | 101 | 191 | 4 | C0234533 | |
| Disease | Clonic Seizures | 4.26e-03 | 101 | 191 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 4.26e-03 | 101 | 191 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 4.26e-03 | 101 | 191 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 4.26e-03 | 101 | 191 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 4.26e-03 | 101 | 191 | 4 | C0751123 | |
| Disease | Complex partial seizures | 4.26e-03 | 101 | 191 | 4 | C0149958 | |
| Disease | Single Seizure | 4.26e-03 | 101 | 191 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 4.26e-03 | 101 | 191 | 4 | C3495874 | |
| Disease | Visual seizure | 4.26e-03 | 101 | 191 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 4.26e-03 | 101 | 191 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 4.26e-03 | 101 | 191 | 4 | C0422855 | |
| Disease | Gustatory seizure | 4.26e-03 | 101 | 191 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 4.26e-03 | 101 | 191 | 4 | C0422850 | |
| Disease | Olfactory seizure | 4.26e-03 | 101 | 191 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 4.26e-03 | 101 | 191 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 4.26e-03 | 101 | 191 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 4.26e-03 | 101 | 191 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 4.26e-03 | 101 | 191 | 4 | C4317109 | |
| Disease | epilepsy (implicated_via_orthology) | 4.26e-03 | 163 | 191 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | SPAST ATP7B ACO2 FASN PTPN14 YAP1 OSBPL11 BOD1L1 MTMR8 DDO RUFY1 RHD LBX1 TRAPPC12 CHD5 | 4.41e-03 | 1074 | 191 | 15 | C0006142 |
| Disease | Absence Seizures | 4.41e-03 | 102 | 191 | 4 | C4316903 | |
| Disease | Convulsions | 4.41e-03 | 102 | 191 | 4 | C4048158 | |
| Disease | Tonic Seizures | 4.41e-03 | 102 | 191 | 4 | C0270844 | |
| Disease | Tremor, Rubral | 4.71e-03 | 16 | 191 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 4.71e-03 | 16 | 191 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 4.71e-03 | 16 | 191 | 2 | C0278161 | |
| Disease | neutrophil collagenase measurement | 4.71e-03 | 16 | 191 | 2 | EFO_0008248 | |
| Disease | Ataxia, Sensory | 4.71e-03 | 16 | 191 | 2 | C0240991 | |
| Disease | central nervous system disease (implicated_via_orthology) | 4.71e-03 | 16 | 191 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Abnormal coordination | 4.71e-03 | 16 | 191 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 4.71e-03 | 16 | 191 | 2 | C0427190 | |
| Disease | Seizures, Focal | 4.73e-03 | 104 | 191 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 4.73e-03 | 104 | 191 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 4.73e-03 | 104 | 191 | 4 | C0494475 | |
| Disease | Schizophrenia | TNIK LAMA1 BACE1 CHD4 ME2 NRXN3 SELENBP1 DDO SLC1A1 SLC1A6 RHD ERVK-8 ATP2A2 | 5.13e-03 | 883 | 191 | 13 | C0036341 |
| Disease | response to radiation, Urinary retention | 5.32e-03 | 17 | 191 | 2 | GO_0009314, HP_0000016 | |
| Disease | partial epilepsy | 5.32e-03 | 17 | 191 | 2 | EFO_0004263 | |
| Disease | esophageal carcinoma, gastric carcinoma | 5.32e-03 | 17 | 191 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | visfatin measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0801230 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 5.32e-03 | 17 | 191 | 2 | OBA_2045063 | |
| Disease | essential hypertension (is_implicated_in) | 5.96e-03 | 18 | 191 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | response to clozapine | 5.96e-03 | 18 | 191 | 2 | GO_0097338 | |
| Disease | Hypertrophic Cardiomyopathy | 6.04e-03 | 57 | 191 | 3 | C0007194 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IGVGGADAVDVMAGI | 206 | Q99798 | |
| SIGDLTMADGVPGVQ | 231 | Q969T7 | |
| EVLASVGGSMIIGGI | 226 | P56817 | |
| AQGTDTILADEMGLG | 716 | Q8TDI0 | |
| MATGTDQVVGLGLVA | 1 | O94777 | |
| IMNELGVTVVGDIIA | 86 | Q8N9M1 | |
| AQADMGVAIGTGTDV | 1276 | P35670 | |
| LQEGLLNIGDSMGEV | 1121 | Q9UIF8 | |
| DMVVFLDGGQLGTLV | 6 | P49640 | |
| MDGIGSEVSEGQVLV | 481 | Q8NB90 | |
| LTDEGVGTDMNEGQL | 1946 | Q12802 | |
| IIIVGVGGADFSAME | 451 | O75131 | |
| DDLLAGMAGGVTVTN | 56 | Q69YQ0 | |
| LLEVVGVTGVVHMGQ | 846 | P52824 | |
| LGLLAAMGAVAGQED | 11 | Q9UKU9 | |
| MIKTADVGVGLAGQE | 946 | O60423 | |
| DVGVGLAGQEGMQAV | 951 | O60423 | |
| VLETIGVLAVIANGM | 601 | A1A5B4 | |
| IEAQDMAGLDVGLTG | 331 | P55290 | |
| MAALVVSGAAEQGGR | 6 | Q9BZG8 | |
| GSVVAMTGDGVNDAV | 636 | P98194 | |
| ALQESGAIVAMTGDG | 661 | O75185 | |
| GAIVAMTGDGVNDAV | 666 | O75185 | |
| DGVGGDSLNMLSVAV | 1161 | Q96BY7 | |
| TLAIGDGANDVGMIQ | 816 | Q9NTI2 | |
| VSMIQVADVGVGISG | 1036 | O60312 | |
| VADVGVGISGQEGMQ | 1041 | O60312 | |
| ADIGIGISGQEGMQA | 1066 | O94823 | |
| VSMIQVADIGIGVSG | 1061 | Q9P241 | |
| VADIGIGVSGQEGMQ | 1066 | Q9P241 | |
| MANVGIAIGTGTDVA | 1311 | Q04656 | |
| LMDQIAVTIVGGHLG | 41 | Q8IXN7 | |
| LMEVVAQDGGALVAS | 316 | Q9Y5G8 | |
| VLGQMVIDEELLGDG | 111 | P28070 | |
| TIMAVQFDGGVVLGA | 36 | P28072 | |
| MGVGLGFAIAAAVVA | 426 | Q9UJ83 | |
| LVAEVNALQGMAAIG | 1236 | Q92621 | |
| EATIGIVDGIFTRMG | 926 | P20585 | |
| VGLMAATLGADVVVT | 81 | Q9H867 | |
| QLMGAAVVSAIAGIA | 1156 | Q5T3U5 | |
| AVAGEDGRMIASQVV | 66 | O60812 | |
| LGVMNEAADEIATGA | 541 | Q8N3A8 | |
| DSVQELMESGQAVGG | 1666 | Q14667 | |
| CAVDVGELVGLGDVM | 56 | Q9H9Y4 | |
| AVAGEDGRMIAGQVL | 66 | P07910 | |
| GRVGMDGTNQSVVIE | 3156 | Q9NZR2 | |
| GLMSDISGQIVLAGD | 901 | Q9BXT6 | |
| QVGETIGISEEIMGL | 961 | O60721 | |
| TTVLVTGAGVGEMVL | 436 | Q8N468 | |
| AINISGDVGISEAMG | 621 | Q96EF0 | |
| LAINQGMEVDLVTGL | 291 | Q13825 | |
| AVAGEDGRMIASQVV | 66 | B7ZW38 | |
| AIGDGGNDVSMIQAA | 871 | O43861 | |
| VVGGTIDVNALEMVA | 4466 | Q2LD37 | |
| GDSDGVNLISMVGEI | 1136 | A9Z1Z3 | |
| LEGMELENQGGVGTE | 361 | Q96KR4 | |
| GDESNIAIGMIAALT | 5371 | Q5CZC0 | |
| EGIEMGVAGSVSLLQ | 301 | Q96MX6 | |
| LNEFLAGEGMTVGEL | 106 | Q96BY2 | |
| AGVGMGAAVLIAAVL | 1256 | Q9ULL4 | |
| IEVQGGLAIDISGAM | 751 | P55157 | |
| AGVISNESGGDVDVM | 446 | Q9H0B8 | |
| GDEILQLGGTAMQGL | 1281 | Q14005 | |
| TVLMLDGEGQSGELQ | 121 | Q9Y4C0 | |
| MVGDTLETDIQGGLN | 186 | Q8TBE9 | |
| MQAGDRLVAVAGESV | 371 | Q86UT5 | |
| LAEMGVAVREDGGTV | 476 | O43896 | |
| EEMLKVGATLTGVGE | 186 | Q969V5 | |
| NTGGITEIMAEGGEL | 211 | Q86W50 | |
| AIIGSDMQEVIGSAI | 156 | P49281 | |
| AVAGEDGRMIASQVV | 66 | P0DMR1 | |
| AAQGLAEVMAGLGVE | 1716 | Q92616 | |
| MIGDDIVGDVGGAQR | 211 | Q9H008 | |
| AAVGTLMTAIGDLGL | 256 | P15289 | |
| VLGVMGAIRNDQGES | 906 | Q7Z3U7 | |
| LTAAGVAVLMEGLAG | 791 | Q86UT6 | |
| TLEKVGMEGGQEAVV | 156 | Q9UKK3 | |
| MDASTQGLLEGIGLD | 1001 | Q7Z6Z7 | |
| AGGMEEVIVAQVDHG | 531 | Q27J81 | |
| GASLGEMAIPAVIGI | 361 | Q5TF39 | |
| QGEVDVLVNNAGMGL | 81 | Q9NYR8 | |
| ALEMAVLEIQGNGES | 266 | Q9UHY1 | |
| SVAGNGAILMIVISD | 36 | P0DN82 | |
| MDTARIAVVGAGVVG | 1 | Q99489 | |
| QLISNMDIDVILGGG | 211 | P05187 | |
| NFSDVAIQGGIMGIE | 241 | Q99572 | |
| EERMVTGAGVVLGDN | 1751 | Q8NFC6 | |
| ILAMGQVDGDLLSGV | 396 | O75084 | |
| MAQAITGVVLGGQVR | 526 | P87889 | |
| MAQAITGVVLGGQVR | 526 | Q9YNA8 | |
| MAQAITGVVLGGQVR | 526 | P62683 | |
| MAQAITGVVLGGQVR | 526 | P63145 | |
| MAQAITGVVLGGQVR | 526 | Q7LDI9 | |
| MAQAITGVVLGGQVR | 526 | P63130 | |
| MAQAITGVVLGGQVR | 526 | P62685 | |
| MAQAITGVVLGGQVR | 526 | P63126 | |
| MSALEVGGLVGSIAA | 266 | O43826 | |
| MAQAITGVVLGGQVR | 526 | P62684 | |
| GTNIAAGKAMGVVVA | 211 | P16615 | |
| AIGTLNVGESMQLEV | 246 | Q4G0P3 | |
| AAGEALGRMAQVVGE | 871 | Q9P2D3 | |
| LQGSGAMPTLVVEEG | 341 | A4D2P6 | |
| VADLGAMVVTGLGGN | 326 | O60341 | |
| LVAGEAAGIMENISD | 706 | O60341 | |
| GVGLAVVNGQLMAVG | 546 | Q9Y2M5 | |
| MGQGDESERIVINVG | 1 | P48547 | |
| IGGVRMLDGEVTDAV | 221 | P09958 | |
| DIDGLESSAIGGQLM | 821 | Q5TH69 | |
| VMLLEAQAATGGIID | 2046 | P15924 | |
| VPIGIGIGNADITEM | 1161 | P12111 | |
| LTGEQALAVLGAMGD | 336 | Q53R41 | |
| DGAREVGNMTGTTEI | 936 | Q3T8J9 | |
| ADGAAEPGVVGQMIE | 461 | P27824 | |
| GGELIISAVAQAIMS | 491 | P36269 | |
| GLVAMAVEGVVGFLL | 1991 | Q9BZC7 | |
| MVVIGAGVIGVELGS | 216 | P09622 | |
| MTNVLGDSIGAAVIE | 506 | P48664 | |
| GAGEAALGIANLIVM | 311 | P23368 | |
| GVVEGAGMVQELDLT | 146 | Q17RN3 | |
| ISEVEAETVGTGIMG | 441 | P32019 | |
| AELLVQMDGVGGTSE | 331 | O75449 | |
| VSVLQAAEGRDGMTI | 101 | P52954 | |
| GAIGDVGILVETMST | 2061 | P49327 | |
| MAEVHVIGQIIGASG | 1 | Q9BPU9 | |
| IDGGITGNMRQEAID | 1096 | Q14839 | |
| LEGFAEGGMIDQETV | 581 | Q9UPN6 | |
| LMAAVQSGGEEANLL | 606 | Q9P1Z2 | |
| IGAAGVPQAGLVTMV | 406 | P43005 | |
| IIVGVGGADFEAMEQ | 446 | Q99829 | |
| VTMVGEGILSLLEHG | 546 | Q9BXB4 | |
| NQDAVATELGILGME | 126 | Q9H814 | |
| EAVEAVAMVGGQLQA | 751 | Q92918 | |
| AVMGVTLTAAIGGAD | 816 | Q13423 | |
| LGIADGMLQTGVTVG | 311 | Q8WWV3 | |
| MGAEEEVLVTLSGGA | 1 | Q9H987 | |
| ELLIQMDGVGGALEN | 331 | Q9BW62 | |
| ALSDIMGAGVVLGSI | 306 | Q96KT7 | |
| EMLGDSEGEGTVQLS | 91 | Q8NC24 | |
| IMLASGAGLEVSVQG | 561 | Q9UGT4 | |
| MAEQLALVIGGTIGG | 1 | Q9BQS2 | |
| VAEQLEVGMVGVNEG | 481 | P51649 | |
| EVGMVGVNEGLISSV | 486 | P51649 | |
| SVDVLMPNVGEIVGG | 461 | O43776 | |
| TVIDMIGVEGFGARE | 711 | A2VDJ0 | |
| AALGALVVLVGMGIA | 56 | Q69YZ2 | |
| EISGGAMAVVAVLLN | 161 | Q15750 | |
| GVAVLGIALIAMGEE | 651 | Q13200 | |
| LEVTAGVGGQEAMLF | 131 | Q9UGC7 | |
| IIVTEAGGVLMDVTG | 226 | P29218 | |
| TGVDVFMDGIQISLG | 41 | Q15669 | |
| DGVVGMGFIEQAIGR | 191 | P00797 | |
| EEEGMVIVGLLVGLN | 246 | Q96T51 | |
| VTVVGDGTMLDVEGL | 2821 | P25391 | |
| GVNVIAMVTAEEEGG | 1001 | Q15678 | |
| AVTGEAAGLALGLVM | 506 | Q99460 | |
| GMEAEVTGVLLVAEG | 311 | Q6ZNE9 | |
| GEEIGMGNIVAANLN | 481 | Q07837 | |
| VGDGTTSVIILAGEM | 91 | P49368 | |
| GSVMLQVDVDTVKGG | 421 | Q13228 | |
| LLMGVGAEGIINVAQ | 476 | A6NM43 | |
| LLMGVGTEGIINVAQ | 476 | Q96SF2 | |
| GDVILAIDGFGTESM | 46 | Q53GG5 | |
| GVQSAGDDRVLVMGA | 471 | Q9UBP0 | |
| GIAMLVSVGNLEEAG | 731 | P08514 | |
| NGLAAGGVDELMGVL | 186 | Q6P1J6 | |
| GTMVGADILAGREDN | 176 | Q8IXU6 | |
| MAGTGLVAGEVVVDA | 1 | O75934 | |
| QGVSGDQVSIMVDGV | 156 | Q92537 | |
| GDIIVAINGESAEGM | 46 | Q96JY6 | |
| MAQAITGVVLGGQVR | 526 | P63128 | |
| GQMVESVAGALGVGL | 116 | P0CW24 | |
| VAGTLTVGDLVMVNG | 401 | O75027 | |
| AVIMSLLEADAGLGG | 601 | O00327 | |
| LGIGITFIDMSVGNV | 476 | Q96P48 | |
| IGQMRDVVGAATAGQ | 876 | Q14028 | |
| LAIGDGANDVSMILE | 821 | P98196 | |
| MFLVGEGDSVITQVL | 426 | O75475 | |
| AATGMIFVLGQAEGI | 376 | Q6UXD7 | |
| GMVIALVDGRGTAFQ | 566 | Q12884 | |
| AGFLAGIGLDVTVMV | 356 | Q16881 | |
| IAGATVLMEGLQAAQ | 11 | Q2L4Q9 | |
| QMQGVGVDNDGILVL | 261 | O75351 | |
| MDVLEGLNVLVTISG | 1091 | Q9UKE5 | |
| LLVLDTVGAGNGMIG | 346 | Q02161 | |
| ASGSIEMQVVAGGDV | 1936 | O75970 | |
| EMQVVAGGDVSVVTG | 1941 | O75970 | |
| IMTGVIGVILGAEAA | 316 | Q6ZMD2 | |
| ILANLEQGLAEDGGM | 511 | Q8WVT3 | |
| GDLVTFSGIEGMVEL | 206 | P41226 | |
| IGIGVQGLADAFILM | 501 | P23921 | |
| VNTGRGMEFEGAIIA | 201 | P61619 | |
| AGVVGGMVDSITQAI | 1821 | Q9Y490 | |
| GMTENVGDSGLRFEI | 1056 | Q96PX9 | |
| VEVDGSIMEGGGQIL | 6 | O00442 | |
| MSGGGEQLDILSVGI | 1 | Q6IQ55 | |
| TNVDLGTLEGDGMNI | 451 | P46937 | |
| QAVLSDDGMGIQAGE | 261 | P30530 | |
| TLGEGEFGAVMEGQL | 541 | P30530 | |
| TDVMGILDGSLGNID | 46 | O94885 | |
| GVGNEVMVVAGVVVL | 31 | Q71RG4 | |
| MAAVVEVEVGGGAAG | 1 | Q9H920 | |
| VVLGVEMTSTGEVAG | 1276 | P27708 | |
| VVESLQLNGGGDVAM | 356 | Q06330 | |
| QLNGGGDVAMLELTG | 361 | Q06330 | |
| LLVQVVMGEELGEQG | 71 | Q96MT0 | |
| MEGLEENGGVVQVGE | 1 | Q96GY0 | |
| PDAIIVIGEGSQMGL | 56 | O00755 | |
| NEAASEVGLVGGMVD | 1816 | Q9Y4G6 | |
| EVGLVGGMVDAIAEA | 1821 | Q9Y4G6 | |
| AVSVGNVGQLAMDLI | 21 | Q969U7 | |
| MIGVAVDTVGILGSN | 311 | Q16401 | |
| GDGTIREGMLVVNGV | 101 | P22735 | |
| LGEAGPVGNMTVVDS | 11 | Q8WUA4 | |
| DGATQVVVVGGSMEG | 1936 | Q9C0G0 | |
| VAGEGAQIIMQEAQG | 2116 | Q9C0G0 | |
| MGGAVFETLEGNTIE | 316 | Q15063 | |
| ENGINGILADEMGLG | 196 | O60264 | |
| QAAMILNELVTGAAG | 521 | O43156 | |
| SGGNEVSIEERLGAM | 431 | Q15061 | |
| EMIEGDLALQGSIGS | 1906 | Q5THJ4 | |
| TGDESIVGLMKDIVG | 111 | Q16719 |